
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC500003C8957F0662B.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="jhepr" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10959701/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10959701/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="JHEP Reports" /><meta name="citation_title" content="Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection" /><meta name="citation_author" content="David C. Trampert" /><meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands" /><meta name="citation_author" content="Remco Kersten" /><meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands" /><meta name="citation_author" content="Dagmar Tolenaars" /><meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands" /><meta name="citation_author" content="Aldo Jongejan" /><meta name="citation_author_institution" content="Department of Epidemiology &#x00026; Data Science, Bioinformatics Laboratory, Amsterdam Public Health Research Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands" /><meta name="citation_author" content="Stan F.J. van de Graaf" /><meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands" /><meta name="citation_author" content="Ulrich Beuers" /><meta name="citation_author_institution" content="Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands" /><meta name="citation_publication_date" content="2024/04" /><meta name="citation_issue" content="4" /><meta name="citation_volume" content="6" /><meta name="citation_doi" content="10.1016/j.jhepr.2024.101015" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10959701/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10959701/" /><meta name="citation_pmid" content="38524667" /><meta name="DC.Title" content="Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Elsevier" /><meta name="DC.Contributor" content="David C. Trampert" /><meta name="DC.Contributor" content="Remco Kersten" /><meta name="DC.Contributor" content="Dagmar Tolenaars" /><meta name="DC.Contributor" content="Aldo Jongejan" /><meta name="DC.Contributor" content="Stan F.J. van de Graaf" /><meta name="DC.Contributor" content="Ulrich Beuers" /><meta name="DC.Date" content="2024 Apr" /><meta name="DC.Identifier" content="10.1016/j.jhepr.2024.101015" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection" /><meta property="og:type" content="article" /><meta property="og:description" content="IgG4-related cholangitis (IRC) is the hepatobiliary manifestation of IgG4-related disease. Anti-laminin 511-E8 autoantibodies have been identified in its pancreatic manifestation. Laminin 511-E8 promotes endothelial barrier function, lymphocyte recruitment, ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10959701/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10959701/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/3793/">JHEP Rep</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/456653/">v.6(4); 2024 Apr</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10959701
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10959701/pdf/main.pdf" class="int-view">PDF (2.8M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10959701/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10959701/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10959701" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10959701%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="TVZtzWacEqhxZYes5yqXHKYDvpWHtl45DfjDwx08MEB927q9RoRfCWYBZ2DGbB04">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10959701%2F&amp;text=Laminin%20511-E8%2C%20an%20autoantigen%20in%20IgG4-related%20cholangitis%2C%20contributes%20to%20cholangiocyte%20protection" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10959701%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10959701/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10959701/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38524667/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10959701/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38524667/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10959701/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10959701/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/3793/">JHEP Rep</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/456653/">v.6(4); 2024 Apr</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10959701
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-jhepr.gif" alt="Logo of jhepr" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://www.journals.elsevier.com/jhep-reports" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">JHEP Rep.</span> 2024 Apr; 6(4): 101015. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2024 Jan 23. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1016%2Fj.jhepr.2024.101015" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.jhepr.2024.101015</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10959701</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38524667">38524667</a></div></div></div><h1 class="content-title">Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Trampert%20DC%5BAuthor%5D" id="au1" class="affpopup" co-rid="_co_idm140089333956992" co-class="co-affbox">David C. Trampert</a>,<sup>1,</sup><sup>&#x02020;</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kersten%20R%5BAuthor%5D" id="au2" class="affpopup" co-rid="_co_idm140089336878992" co-class="co-affbox">Remco Kersten</a>,<sup>1,</sup><sup>&#x02020;</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tolenaars%20D%5BAuthor%5D" id="au3" class="affpopup" co-rid="_co_idm140089332468016" co-class="co-affbox">Dagmar Tolenaars</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jongejan%20A%5BAuthor%5D" id="au4" class="affpopup" co-rid="_co_idm140089335528528" co-class="co-affbox">Aldo Jongejan</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=van%20de%20Graaf%20SF%5BAuthor%5D" id="au5" class="affpopup" co-rid="_co_idm140089335526304" co-class="co-affbox">Stan F.J. van de Graaf</a>,<sup>1</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Beuers%20U%5BAuthor%5D" id="au6" class="affpopup" co-rid="_co_idm140089335524080" co-class="co-affbox">Ulrich Beuers</a><sup>1,</sup><sup>&#x02217;</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140089333956992"><h3 class="no_margin">David C. Trampert</h3><p><sup>1</sup>Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Trampert%20DC%5BAuthor%5D">David C. Trampert</a></div></div><div id="_co_idm140089336878992"><h3 class="no_margin">Remco Kersten</h3><p><sup>1</sup>Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kersten%20R%5BAuthor%5D">Remco Kersten</a></div></div><div id="_co_idm140089332468016"><h3 class="no_margin">Dagmar Tolenaars</h3><p><sup>1</sup>Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tolenaars%20D%5BAuthor%5D">Dagmar Tolenaars</a></div></div><div id="_co_idm140089335528528"><h3 class="no_margin">Aldo Jongejan</h3><p><sup>2</sup>Department of Epidemiology &#x00026; Data Science, Bioinformatics Laboratory, Amsterdam Public Health Research Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Jongejan%20A%5BAuthor%5D">Aldo Jongejan</a></div></div><div id="_co_idm140089335526304"><h3 class="no_margin">Stan F.J. van de Graaf</h3><p><sup>1</sup>Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=van%20de%20Graaf%20SF%5BAuthor%5D">Stan F.J. van de Graaf</a></div></div><div id="_co_idm140089335524080"><h3 class="no_margin">Ulrich Beuers</h3><p><sup>1</sup>Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Beuers%20U%5BAuthor%5D">Ulrich Beuers</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140089373611824_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140089373611824_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140089373611824_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140089373611824_ai" style="display:none"><div class="fm-affl" id="aff1"><sup>1</sup>Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands</div><div class="fm-affl" id="aff2"><sup>2</sup>Department of Epidemiology &#x00026; Data Science, Bioinformatics Laboratory, Amsterdam Public Health Research Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands</div><div><span class="contrib-email" id="au6">Ulrich Beuers: <a href="mailto:dev@null" data-email="ln.cmumadretsma@sreueb.h.u" class="oemail">ln.cmumadretsma@sreueb.h.u</a></span> </div><div id="cor1"><sup>&#x02217;</sup>Corresponding author. Address: Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, University of Amsterdam, Location AMC (C2-327), Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Tel.: +31-20-5662422; Fax: +31-20-5669701. <a href="mailto:dev@null" data-email="ln.cmumadretsma@sreueb.h.u" class="oemail">ln.cmumadretsma@sreueb.h.u</a></div><div id="fn1"><sup>&#x02020;</sup>These authors contributed equally to this work and share first authorship.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140089373611824_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 Jun 19; Revised 2024 Jan 4; Accepted 2024 Jan 11.</div></div><div class="permissions half_rhythm hide" id="idm140089373611824_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2024 The Author(s)</div><div class="license half_rhythm">This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="4" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Multimedia component 1</div><div><a href="/pmc/articles/PMC10959701/bin/mmc1.docx" data-ga-action="click_feat_suppl">mmc1.docx</a><span style="color:gray"> (22M)</span></div><div class="small guid">GUID: 91C6D78B-A93F-4CD8-AFB1-ED67B15ED5D2</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Multimedia component 2</div><div><a href="/pmc/articles/PMC10959701/bin/mmc2.docx" data-ga-action="click_feat_suppl">mmc2.docx</a><span style="color:gray"> (58K)</span></div><div class="small guid">GUID: 7DC8280C-A622-4080-93D3-7DB0B3B23A12</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Multimedia component 3</div><div><a href="/pmc/articles/PMC10959701/bin/mmc3.pdf" data-ga-action="click_feat_suppl">mmc3.pdf</a><span style="color:gray"> (460K)</span></div><div class="small guid">GUID: 927C4912-DCC6-4B81-BF8C-37DEEEE0F460</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Multimedia component 4</div><div><a href="/pmc/articles/PMC10959701/bin/mmc4.pdf" data-ga-action="click_feat_suppl">mmc4.pdf</a><span style="color:gray"> (6.1M)</span></div><div class="small guid">GUID: 8CC067FF-B465-4167-9AB1-83CC339692E4</div></div></dd></dl><dl data-length="218" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">RNA sequencing data were submitted to NCBI Gene Expression Omnibus (GEO) and are freely available under GEO accession number <a class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE221746" ref="/geo/query/acc.cgi?acc=GSE221746"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE221746","term_id":"221746","extlink":"1"}}</span>GSE221746</a>.</p></dd></dl></div><div id="abs0010" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0010title">Abstract</h2><!--article-meta--><div><div id="sec-a.t.b.p.a" class="sec sec-first"><h3 id="sec-a.t.b.p.atitle">Background &#x00026; Aims</h3><p class="p p-first-last">IgG4-related cholangitis (IRC) is the hepatobiliary manifestation of IgG4-related disease. Anti-laminin 511-E8 autoantibodies have been identified in its pancreatic manifestation. Laminin 511-E8 promotes endothelial barrier function, lymphocyte recruitment, and cholangiocyte differentiation. Here, we investigate anti-laminin 511-E8 autoantibody presence in IRC, and mechanisms via which laminin 511 may contribute to cholangiocyte protection.</p></div><div id="sec-a.t.b.p.b" class="sec"><h3 id="sec-a.t.b.p.btitle">Methods</h3><p class="p p-first-last">Anti-laminin 511-E8 serum autoantibody positivity was assessed by ELISA. RNA sequencing and RT-qPCR were performed on human H69 cholangiocytes treated with recombinant laminin 511-E8. H69 cholangiocytes were subjected to shRNA knockdown targeting genes encoding laminin 511 (<em>LAMA5</em>, <em>LAMB1</em>, <em>LAMC1</em>) or treated with recombinant laminin 511-E8. Cholangiocellular bile acid influx was quantified radiochemically using 22,23-<sup>3</sup>H-glycochenodeoxycholic acid (GCDC). GCDC-induced apoptosis was determined by Caspase-3/7 assays. Cholangiocellular barrier function was assessed by FITC-Dextran permeability assays. Immunofluorescent staining of laminin 511 and claudin 1 was performed on extrahepatic bile duct tissue of control and anti-laminin 511-E8 positive individuals with IRC.</p></div><div id="sec-a.t.b.p.c" class="sec"><h3 id="sec-a.t.b.p.ctitle">Results</h3><p class="p p-first-last">Seven out of 52 individuals with IRC had autoantibodies against laminin 511-E8. Recombinant laminin 511-E8 led to differential expression of genes involved in secretion, barrier function, and inflammation. Knockdown of laminin 511 constituents increased toxic bile acid permeation and GCDC-induced apoptosis. Laminin 511-E8 treatment decreased toxic bile acid permeation and dose-dependently alleviated GCDC-induced apoptosis. <em>LAMA5</em> and <em>LAMC1</em> knockdown increased transepithelial permeability. Laminin 511-E8 treatment reduced transepithelial permeability and prevented T lymphocyte-induced barrier dysfunction. Laminin 511 and claudin 1 staining patterns appeared altered in anti-laminin 511-E8 positive individuals with IRC.</p></div><div id="sec-a.t.b.p.d" class="sec"><h3 id="sec-a.t.b.p.dtitle">Conclusions</h3><p class="p p-first-last">Laminin 511-E8 is an autoantigen in subsets of individuals with IRC. Laminin 511 enhances cholangiocellular barrier function and protects cholangiocytes against T lymphocyte-induced barrier dysfunction, toxic bile acid permeation and bile acid-induced apoptosis.</p></div><div id="sec-a.t.b.p.e" class="sec sec-last"><h3 id="sec-a.t.b.p.etitle">Impact and implications</h3><p class="p p-first-last">A subset of patients with IgG4-related cholangitis (IRC) has autoantibodies against laminin 511-E8. In human cholangiocytes, laminin 511 protects against (T lymphocyte-induced) epithelial barrier dysfunction and hydrophobic bile acids. Laminin 511 and claudin 1 staining may be altered in extrahepatic bile ducts of patients with IRC who are anti-laminin 511-E8 positive. This makes it tempting to speculate that a decreased epithelial barrier function with attraction of immune cells and impaired bicarbonate secretion as a result of dysfunction of laminin 511 by autoantibody binding could potentially be a common systemic pathogenic mechanism in a subset of patients with IgG4-RD.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Activated T lymphocytes, Biliary bicarbonate umbrella, Cholangiopathy, Epithelial barrier function, GCDC, Glycochenodeoxycholate, Hydrophobic bile acids, IgG4-related disease, IgG4-RD, Immune-mediated disease, Laminin</span></div></div><div id="abs0015" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0015title">Graphical abstract</h2><!--article-meta--><div><!--fig ft0--><!--fig @position="anchor" mode=article f4--><!--fig mode="anchored" f5--><div class="fig graphic_only iconblock anchored whole_rhythm" id="undfig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140089373108160"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ga1.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is ga1.jpg" src="/pmc/articles/PMC10959701/bin/ga1.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140089373108160"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/figure/undfig1/?report=objectonly">Open in a separate window</a></div></div></div></div><div id="abs0020" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0020title">Highlights</h2><!--article-meta--><div><ul class="simple" style="list-style-type:none" id="ulist0010"><li class="a_label" id="u0010"><div class="inline_block a_label">&#x02022;</div><div id="p0010">Laminin 511-E8 is an autoantigen in a subset of individuals with IRC.</div></li><li class="a_label" id="u0015"><div class="inline_block a_label">&#x02022;</div><div id="p0015">Laminin 511 protects cholangiocytes against toxic bile acids.</div></li><li class="a_label" id="u0020"><div class="inline_block a_label">&#x02022;</div><div id="p0020">Laminin 511 improves cholangiocellular barrier function.</div></li><li class="a_label" id="u0025"><div class="inline_block a_label">&#x02022;</div><div id="p0025">Laminin 511 protects the cholangiocyte barrier from T lymphocyte-induced damage.</div></li><li class="a_label" id="u0030"><div class="inline_block a_label">&#x02022;</div><div id="p0030">Laminin 511 and claudin 1 expression may be altered in individuals with IRC.</div></li></ul><p></p></div></div><div id="sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1title">Introduction</h2><p id="p0035" class="p p-first">IgG4-related disease (IgG4-RD) is a systemic, lymphocyte driven, fibroinflammatory disorder characterized by elevated IgG4 serum levels and typical histopathological findings in affected organs. The most common abdominal organ manifestations in IgG4-RD are autoimmune pancreatitis (type I AIP) and IgG4-related cholangitis (IRC).<a href="#bib1" rid="bib1" class=" bibr popnode"><sup>1</sup></a><sup>,</sup><a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a> The fibroinflammatory nature of IRC leads to thickening of the bile duct wall and stenosis formation, both of which are features overlapping with hallmark signs of primary sclerosing cholangitis (PSC) and cholangiocarcinoma (CCA). Currently, no single accurate diagnostic test is available to distinguish IRC from these conditions. IRC therefore presents a major diagnostic challenge, with misdiagnosis and unjustified major surgical resections being a relatively common occurrence (<a href="#appsec1" rid="appsec1" class=" sec">Table S1</a>).<a href="#bib3" rid="bib3" class=" bibr popnode"><sup>3</sup></a></p><p id="p0040">In light of this clinical problem, understanding the pathogenesis of IRC is of great importance.</p><p id="p0045">Previous studies have demonstrated the presence of affinity-maturated dominant B cell receptor clones in peripheral blood and affected tissue of individuals with IgG4-RD.<a href="#bib4" rid="bib4" class=" bibr popnode">[4]</a>, <a href="#bib5" rid="bib5" class=" bibr popnode">[5]</a>, <a href="#bib6" rid="bib6" class=" bibr popnode">[6]</a> This raised the suspicion that specific autoantibodies are present in patients with IgG4-RD and led to the discovery of the autoantigens annexin A11 (ANXA11), galectin-3, laminin 511-E8, and prohibitin 1.<a href="#bib7" rid="bib7" class=" bibr popnode">[7]</a>, <a href="#bib8" rid="bib8" class=" bibr popnode">[8]</a>, <a href="#bib9" rid="bib9" class=" bibr popnode">[9]</a> The pathogenicity of autoantibodies was strongly suggested after injection of patient-derived IgG1 or IgG4 autoantibodies into mice led to the development of typical organ lesions in salivary glands and pancreas which were more intense after IgG1 than IgG4 injection.<a href="#bib10" rid="bib10" class=" bibr popnode"><sup>10</sup></a> Simultaneous injection showed that IgG4 alleviated the more pathogenic effects of IgG1. In the same line, IgG4 autoantibodies directed against annexin A11 blocked binding of IgG1 autoantibodies to annexin A11 supporting an anti-inflammatory role of IgG4 in IgG4-RD.<a href="#bib7" rid="bib7" class=" bibr popnode"><sup>7</sup></a> Additional support for the pathogenicity of autoantibodies in IgG4-RD comes from the observation that individuals with IgG4-RD who are positive for multiple autoantibodies have increased disease severity<a href="#bib11" rid="bib11" class=" bibr popnode"><sup>11</sup></a> and that autoantibody levels decrease after successful treatment.<a href="#bib8" rid="bib8" class=" bibr popnode"><sup>8</sup></a> Autoantibodies could potentially contribute to the pathogenesis of IgG4-RD either by directly interfering with the endogenous function of the targeted autoantigen or by eliciting an excessive immune response after binding to the autoantigen. To address the potential direct pathogenicity of these autoantibodies, an improved understanding of the physiological role of the targeted autoantigens is pivotal.</p><p id="p0050">To this end, we have previously investigated the role of the autoantigen annexin A11 in cholangiocytes,<a href="#bib12" rid="bib12" class=" bibr popnode"><sup>12</sup></a> which has a critical role in trafficking anoctamin 1 (ANO1), a calcium-activated chloride channel, to the apical cholangiocyte membrane. Patient serum containing autoantibodies directed against annexin A11 inhibited the membrane trafficking of ANO1, thereby potentially preventing its function at the plasma membrane of establishing a chloride gradient to facilitate biliary bicarbonate secretion. Biliary bicarbonate secretion is thought to keep millimolar levels of bile salts within the bile duct lumen in their deprotonated, membrane-impermeable and thus non-toxic state.<a href="#bib13" rid="bib13" class=" bibr popnode"><sup>13</sup></a><sup>,</sup><a href="#bib14" rid="bib14" class=" bibr popnode"><sup>14</sup></a> These findings are of interest as the autoantigen laminin 511-E8 has been shown to promote the differentiation of induced pluripotent stem cells (iPSCs) towards cholangiocytes with upregulation of secretory components such as the cystic fibrosis transmembrane conductance regulator (<em>CFTR</em>), the G protein-coupled bile acid receptor 1 (<em>GPBAR1</em>, <em>TGR5</em>), and secretin receptor (<em>SCTR</em>), which are all instrumental in adequate apical bicarbonate secretion.<a href="#bib15" rid="bib15" class=" bibr popnode"><sup>15</sup></a> Laminin 511 is a heterotrimeric extracellular matrix protein composed of the subunits alpha-5, beta-1, and gamma-1.<a href="#bib16" rid="bib16" class=" bibr popnode"><sup>16</sup></a> Anti-laminin 511 autoantibodies are directed against the cell-binding proteolytic laminin 511-E8 fragment in type 1 AIP.<a href="#bib8" rid="bib8" class=" bibr popnode"><sup>8</sup></a></p><p id="p0055">In addition to potential secretory defects in IRC, an impaired cholangiocellular barrier function has been proposed to play a role in IRC. Bile and brush cytology samples taken upon endoscopic retrograde cholangiopancreaticography (ERCP) from individuals with IRC demonstrated an increase in the T cell cytokines IL-4 and IL-13.<a href="#bib17" rid="bib17" class=" bibr popnode"><sup>17</sup></a> These cytokines negatively impacted cholangiocellular barrier function <em>in&#x000a0;vitro</em> through differential expression of tight junction-associated claudin genes <em>CLDN1</em> and <em>CLDN2</em>. Numerous T cell populations are involved in the pathogenesis of IgG4-RD including regulatory T cells, follicular T helper 2, T peripheral helper, and cytotoxic CD8<sup>+</sup> and CD4<sup>+</sup> T cells.<a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a><sup>,</sup><a href="#bib18" rid="bib18" class=" bibr popnode"><sup>18</sup></a> Notably in endothelial cells, laminin 511 has been shown to strengthen endothelial barrier function by stabilizing vascular endothelial-cadherin and increasing the expression of tight junction proteins.<a href="#bib19" rid="bib19" class=" bibr popnode"><sup>19</sup></a> At the endothelial barrier, laminin 511 prevents the extravasation of leukocytes<a href="#bib20" rid="bib20" class=" bibr popnode"><sup>20</sup></a><sup>,</sup><a href="#bib21" rid="bib21" class=" bibr popnode"><sup>21</sup></a> and activation of T cells.<a href="#bib22" rid="bib22" class=" bibr popnode"><sup>22</sup></a></p><p id="p0060" class="p p-last">In the present study, we investigate whether laminin 511-E8 is an autoantigen in IgG4-related cholangitis and study the role of laminin 511 in human cholangiocytes. Based on our own studies and the current literature, we hypothesize that laminin 511 protects cholangiocytes against toxic bile acids and prevents T lymphocyte-induced barrier dysfunction.</p></div><div id="sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2title">Patients and methods</h2><div id="sec2.1" class="sec sec-first"><h3 id="sec2.1title">Human ethics statement</h3><p id="p0065" class="p p-first-last">The use of serum samples and peripheral blood mononuclear cells (PBMCs) was approved by the local medical ethical committee in Amsterdam (MEC 10/007 and MEC 2020/081). All participants gave written informed consent before inclusion in the study. Resection specimens of extrahepatic bile duct tissue from control and anti-laminin 511-E8 positive individuals with IRC were obtained from the Amsterdam UMC HPB Pathology biobank (TcB2018-063).</p></div><div id="sec2.2" class="sec"><h3 id="sec2.2title">Participants</h3><p id="p0070" class="p p-first-last">Serum samples were obtained from individuals with IRC, PSC, CCA, and healthy volunteers. Diagnosis of IRC was made according to the HISORt criteria (histology, imaging, serology, other organ involvement, response to therapy),<a href="#bib23" rid="bib23" class=" bibr popnode"><sup>23</sup></a> whereas diagnosis of PSC was made according to the EASL Clinical Practice Guidelines on sclerosing cholangitis.<a href="#bib24" rid="bib24" class=" bibr popnode"><sup>24</sup></a> Diagnosis of CCA was made based on histopathology.</p></div><div id="sec2.3" class="sec"><h3 id="sec2.3title">ELISA</h3><p id="p0075" class="p p-first-last">Alternating rows of 96-well ELISA plates were coated with 100&#x000a0;&#x003bc;l human recombinant laminin 511-E8 (2&#x000a0;&#x003bc;g/ml) or bovine serum albumin (2&#x000a0;&#x003bc;g/ml) in coating buffer (50&#x000a0;mM carbonate/bicarbonate pH 9.6 and incubated at 37&#x000a0;&#x000b0;C for 1&#x000a0;h.<a href="#bib11" rid="bib11" class=" bibr popnode"><sup>11</sup></a> Wells were washed with 50&#x000a0;mM Tris-buffered saline (TBS) with 0.05% Tween (TBST) pH 8.0 and subsequently blocked for 1&#x000a0;h with 1% bovine serum albumin (BSA)/TBS pH 8.0 at room temperature. Wells were again washed and incubated with diluted sera from patients with IRC, PSC, CCA, or healthy controls (1:20 in 1% BSA/TBS pH 8.0) for 30&#x000a0;min at room temperature. After washing, wells were incubated for 1&#x000a0;h at room temperature with 0.65&#x000a0;&#x003bc;g/ml of rabbit anti-human IgG horseradish peroxidase (HRP) secondary antibody. After washing, bound reactants were detected after a 5-min incubation with 100&#x000a0;&#x003bc;l of the chromogenic substrate 3,3&#x02032;,5,5&#x02032;-tetramethylbenzidine. The reaction was stopped with 100&#x000a0;&#x003bc;l of stop solution and absorbance was determined at 450&#x000a0;nm using the CLARIOstar (BMG LABTECH, Ortenberg, Germany). Samples were considered positive for autoantibodies against laminin 511-E8 when absorbance values were greater than the mean plus two standard deviations of the healthy control group as previously described.<a href="#bib9" rid="bib9" class=" bibr popnode"><sup>9</sup></a><sup>,</sup><a href="#bib11" rid="bib11" class=" bibr popnode"><sup>11</sup></a></p></div><div id="sec2.4" class="sec"><h3 id="sec2.4title">Cell cultures</h3><p id="p0080" class="p p-first-last">H69 cholangiocytes were kindly provided by Dr Douglas Jefferson (Tufts University, Boston, MS, USA) and were cultured as previously described.<a href="#bib25" rid="bib25" class=" bibr popnode"><sup>25</sup></a> Composition of H69 culture medium can be found in <a href="#appsec1" rid="appsec1" class=" sec">Table&#x000a0;S2</a>. Culture details on LX2 cells can be found in the <a href="#appsec1" rid="appsec1" class=" sec">Supplementary methods</a>. <em>Mycoplasma</em> contamination tests were carried out every 3 months with negative results throughout.</p></div><div id="sec2.5" class="sec"><h3 id="sec2.5title">RNA sequencing</h3><p id="p0085" class="p p-first-last">H69 cholangiocytes were treated with recombinant human laminin 511-E8 0.25&#x000a0;&#x003bc;g/cm<sup>2</sup> for 48&#x000a0;h. After RNA isolation by spin column, concentration, and quality were assessed using the RNA ScreenTape. Library preparation by poly(A) mRNA capture was performed using KAPA mRNA Hyperprep. Samples were pair-end sequenced (150 bp) on the NovaSeq (Illumina, San Diego, CA, USA) with a sequencing depth of 40 million reads per sample. Raw data were submitted to NCBI Gene Expression Omnibus (GEO) and are freely available under GEO accession number <a id="__tag_1145657175" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE221746" ref="/geo/query/acc.cgi?acc=GSE221746"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE221746","term_id":"221746","extlink":"1"}}</span>GSE221746</a>. For the RNA sequencing data analysis pipeline used, see the <a href="#appsec1" rid="appsec1" class=" sec">Supplementary methods</a>.</p></div><div id="sec2.6" class="sec"><h3 id="sec2.6title">Human PBMCs isolation and activation of T lymphocytes</h3><p id="p0090" class="p p-first-last">Isolation of PBMCs, depletion of monocytes/macrophages by the adherence method, and activation of T lymphocytes was performed as previously described.<a href="#bib26" rid="bib26" class=" bibr popnode">[26]</a>, <a href="#bib27" rid="bib27" class=" bibr popnode">[27]</a>, <a href="#bib28" rid="bib28" class=" bibr popnode">[28]</a> Peripheral blood was obtained from healthy volunteers and transferred to 50-ml conical tubes in an ML-2/BSL-2 facility. Ficoll-Paque Plus was added to the bottom of the 50-ml conical tube and centrifuged to generate a gradient. The PBMC layer was collected in a new tube, diluted with sterile filtered 0.2% BSA 2 mM EDTA in PBS and centrifuged. Supernatant was discarded and PBMCs were resuspended in Iscove&#x02019;s modified Dulbecco&#x02019;s medium (IMDM) supplemented with 10% fetal bovine serum and 37.5 U/ml (1%) penicillin, 37.5 &#x003bc;g/ml (1%) streptomycin. PBMCs were seeded in culture plates for 2 h to deplete monocytes/macrophages by adherence and T lymphocytes were stimulated using phorbol-12-myristate-13-acetate (PMA) 50 ng/ml and ionomycin 1000 ng/ml.<a href="#bib28" rid="bib28" class=" bibr popnode"><sup>28</sup></a> Non-adherent activated T lymphocytes were collected and centrifuged. Pelleted cells were resuspended in supplemented IMDM and counted for co-culture plating.</p></div><div id="sec2.6.1" class="sec"><h3 id="sec2.6.1title">Fluorescein isothiocyanate&#x02013;Dextran permeability assay in a Transwell co-culture system</h3><p id="p0095" class="p p-first-last">On Day 0, 12-well Transwell inserts were coated with 10 &#x003bc;g/ml human recombinant laminin 511-E8 in sterile PBS or 10 &#x003bc;g/ml BSA control coating, and left to dry for 1 h at 37 &#x000b0;C. After coating, H69 cholangiocytes were seeded in the apical compartment at 100,000 cells per insert. On Day 4, PBMCs were isolated from healthy volunteers, and T lymphocytes were activated with PMA and ionomycin, after which 200,000 cells were added to the basolateral compartment. The apical compartment was refreshed with H69 culture medium and the basolateral compartment contained supplemented IMDM with or without activated T lymphocytes. Co-culture was left overnight. On Day 5, 4 kDa fluorescein isothiocyanate (FITC)-Dextran permeability assays were performed. For this, medium was refreshed with 800 &#x003bc;l DMEM supplemented with 10% FBS and 37.5 U/ml (1%) penicillin, 37.5 &#x003bc;g/ml (1%) streptomycin on the basolateral side, and 250 &#x003bc;l of supplemented DMEM containing 1 mg/ml 4 kDa FITC&#x02013;Dextran on the apical side. At timepoint 0, 100 &#x003bc;l of medium was transferred to a black 96-well plate to determine potential background fluorescence. In addition, an empty unseeded Transwell insert was included to determine maximal permeability of the insert itself. At t = 60, 120, 180, and 240 min, 100 &#x003bc;l of basolateral medium was collected per experimental condition and transferred to the black 96-well plate. FITC&#x02013;Dextran fluorescence (excitation 490 nm, emission 520 nm) was measured using the CLARIOstar apparatus.</p></div><div id="sec2.6.2" class="sec"><h3 id="sec2.6.2title">Lentivirus generation and transduction for shRNA-mediated knockdown</h3><p id="p0100" class="p p-first-last">Lentiviral short hairpin RNA (shRNA) constructs were purchased from the MISSION&#x000ae; TRC version 1 shRNA library (Sigma-Aldrich, St. Louis, MO, USA): <em>LAMA5</em> (TCRN0000119152), <em>LAMB1</em> (TRCN0000083431), <em>LAMC1</em> (TRCN0000119110) and the non-targeting shRNA control (SHC002). Lentivirus was produced as previously described in an ML-2/BSL-2 facility.<a href="#bib29" rid="bib29" class=" bibr popnode"><sup>29</sup></a> Transduced H69 cholangiocytes were selected with 1 &#x003bc;g/ml puromycin to obtain stable <em>LAMA5</em>, <em>LAMB1,</em> and <em>LAMC1</em> knockdown cholangiocytes.</p></div><div id="sec2.6.3" class="sec"><h3 id="sec2.6.3title">Western blotting</h3><p id="p0105" class="p p-first-last">Cells were lysed in radioimmunoprecipitation assay buffer and lysate samples were prepared in lithium dodecyl sulfate sample buffer. After running the samples on SDS-PAGE gels (3&#x02013;15% Tris-acetate for LAMA5, 4&#x02013;10% Tris-glycine for LAMB1 and LAMC1) in running buffer (50 mM tricine, 50 mM Tris, 0.1% SDS, and 1.3 mM sodium bisulfite at pH 8.2), samples were transferred by wet-transfer in ethanolamine/glycine transfer buffer to polyvinylidene difluoride membranes, blocked for 2 h at room temperature in 5% non-fat milk/TBST and probed overnight at 4 &#x000b0;C with the respective primary antibody (see <a href="#appsec1" rid="appsec1" class=" sec">CTAT methods</a>). Immune complexes were detected with HRP-conjugated secondary antibodies and visualized using enhanced chemiluminescence detection reagent (Lumi-light, Roche Diagnostics, Rotkreuz, Switzerland) and ImageQuant LAS 4000 (GE Healthcare, Chicago, IL, USA). Protein bands were quantified using ImageJ 1.50i (Wayne Rasband, National Institutes of Health, Bethesda, MD, USA). Results were presented as fold changes of control (shRNA control; SHC002) transduced H69 cells, normalized per experiment.</p></div><div id="sec2.6.4" class="sec"><h3 id="sec2.6.4title">RNA isolation, cDNA synthesis, and real-time quantitative PCR</h3><p id="p0110" class="p p-first-last">For RNA isolation, cDNA synthesis, primer design, RT-qPCR and data analysis, see <a href="#appsec1" rid="appsec1" class=" sec">Supplementary methods</a>.</p></div><div id="sec2.6.5" class="sec"><h3 id="sec2.6.5title">Bile acid permeation assay</h3><p id="p0115" class="p p-first-last">Bile acid permeation assays were performed as previously described.<a href="#bib12" rid="bib12" class=" bibr popnode"><sup>12</sup></a></p></div><div id="sec2.6.6" class="sec"><h3 id="sec2.6.6title">Caspase-3/7 assay</h3><p id="p0120" class="p p-first-last">Apoptosis was determined with Caspase-3/7 assays in H69 cholangiocytes exposed to 1,500 &#x003bc;M glycochenodeoxycholic acid (GCDC) or 10 &#x003bc;M Raptinal as a positive control as described previously.<a href="#bib13" rid="bib13" class=" bibr popnode"><sup>13</sup></a><sup>,</sup><a href="#bib30" rid="bib30" class=" bibr popnode"><sup>30</sup></a></p></div><div id="sec2.6.7" class="sec"><h3 id="sec2.6.7title">Immunofluorescent staining and confocal microscopy</h3><p id="p0125" class="p p-first-last">Paraffin-embedded extrahepatic bile duct tissue of control and anti-laminin 511-E8 positive individuals with IRC were sectioned at 4 &#x003bc;m thickness. Slides were deparaffinized, re-hydrated and unmasked in a steamed Trilogy (Cell Marque) solution. Additional antigen retrieval was done in steamed 10 mM sodium citrate (Sigma) solution. Autofluorescence was quenched using 50 mM NH<sub>4</sub>Cl in PBS pH 7.4 at room temperature. Slides were blocked in 5% normal goat serum in 1% BSA/TBST for 1 h. Primary antibodies were added to the tissue sections at a 1:100 dilution in 1% BSA in TBST overnight at 4 &#x000b0;C. Alexa Fluor 488 was used as secondary antibody for laminin 511-E8 and claudin 1, whereas Alexa Fluor 568 and 594 were used for cytokeratin 7 alongside Hoechst 33324 for nuclear staining. See <a href="#appsec1" rid="appsec1" class=" sec">CTAT methods</a> for all antibodies used. Tissue sections were mounted with Prolong Gold antifade (Invitrogen) and 1.5 mm cover glasses. Stainings were imaged using the SP8-X DLS LightSheet confocal microscope by a researcher blinded to patient conditions. Three randomly selected fields were captured for each condition.</p></div><div id="sec2.7" class="sec sec-last"><h3 id="sec2.7title">Statistical analysis</h3><p id="p0130" class="p p-first-last">Data are presented as means with standard deviations. Statistical analyses were performed with GraphPad Prism 9 (GraphPad, La Jolla, CA, USA). Results of two groups were compared with a paired or unpaired <em>t</em> test where appropriate. One-way ANOVA was used when comparing multiple groups. Values of <em>p</em> &#x0003c;0.05 were considered statistically significant.</p></div></div><div id="sec3" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3title">Results</h2><div id="sec3.1" class="sec sec-first"><h3 id="sec3.1title">Autoantibodies against laminin 511-E8 are present in a subset of individuals with IRC</h3><p id="p0135" class="p p-first-last">Seven out of 52 individuals with IRC (13.5%) were found to have autoantibodies against laminin 511-E8, but none of the disease controls with PSC (n&#x000a0;= 13) or CCA (n&#x000a0;= 14). One of 13 healthy volunteers had autoantibodies against laminin 511-E8 (7.7%) (<a href="/pmc/articles/PMC10959701/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>A). IgG subtype classification showed that two individuals with IRC had autoantibodies of the IgG1 subtype, one had autoantibodies of the IgG4 subtype and one had autoantibodies of both the IgG1 and IgG4 subtype (<a href="/pmc/articles/PMC10959701/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>B and C). There were no differences between individuals with IRC positive or negative for laminin 511-E8 autoantibodies regarding age, sex, multi-organ involvement, the occurrence of malignancies, major hepatobiliary surgeries or serum liver and inflammatory tests at presentation (<a href="/pmc/articles/PMC10959701/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table&#x000a0;1</span></a>). Six out of seven patients had a history of &#x02018;blue-collar work&#x02019;, that is, skilled trades frequently involving manual labor, and had been exposed to occupational toxins and&#x000a0;chemicals (<em>e.g.</em> gases, fumes, mineral dusts) for &#x0003e;1 year (<a href="/pmc/articles/PMC10959701/table/tbl2/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span>Table 2</span></a>).<a href="#bib31" rid="bib31" class=" bibr popnode"><sup>31</sup></a><sup>,</sup><a href="#bib32" rid="bib32" class=" bibr popnode"><sup>32</sup></a> Four laminin 511-E8 positive individuals with IgG4-RD had manifestations in other secretory organs, namely the pancreas, salivary glands, kidneys, lungs, and colon. Autoantibodies targeting other autoantigens were found in six IRC-affected individuals and four underwent major hepatobiliary surgeries for the suspicion of CCA (<a href="#appsec1" rid="appsec1" class=" sec">Table&#x000a0;S1</a>). Malignancy occurred in four individuals either before or after the diagnosis of IRC. In four individuals there was a considerable delay in the diagnosis of IRC, ranging from 9 to 360 months. Owing to the diagnostic challenge of IRC and accompanying initial misdiagnosis, patients were treated in different ways, with varying rates of clinical and biochemical success (<a href="#appsec1" rid="appsec1" class=" sec">Fig.&#x000a0;S1</a>). Thus, in our IRC cohort no relevant occupational, clinical, or biochemical differences were observed between laminin 511-E8-positive and -negative individuals.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig1" co-legend-rid="lgnd_fig1"><a href="/pmc/articles/PMC10959701/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140089332448384"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10959701_gr1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10959701/bin/gr1.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140089332448384"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/figure/fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig1"><div><a class="figpopup" href="/pmc/articles/PMC10959701/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1">Fig.&#x000a0;1</a></div><!--caption a7--><div class="caption"><p>Laminin 511-E8 is an autoantigen in a subset of patients with IRC.</p><p>(A) Anti-laminin 511-E8 IgG in patients with IRC (7/52), PSC (0/13), CCA (0/14) and healthy controls (1/13). Anti-laminin 511-E8 IgG1 (B) and IgG4 (C) subtype classification in positive patients with IRC. Patients are presented as individual data points and positive patients are annotated. CCA, cholangiocarcinoma; IRC, IgG4-related cholangitis; PSC, primary sclerosing cholangitis.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl1"><h3>Table&#x000a0;1</h3><!--caption a7--><div class="caption"><p>Comparison of IRC patients positive and negative for anti-laminin 511-E8 autoantibodies.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1">Positive</th><th rowspan="1" colspan="1">Negative</th><th rowspan="1" colspan="1"><em>p</em> value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">IRC patients, n (%)</td><td rowspan="1" colspan="1">7 (13.5)</td><td rowspan="1" colspan="1">45 (86.5)</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">Sex (male/female)</td><td rowspan="1" colspan="1">5/2</td><td rowspan="1" colspan="1">41/4</td><td rowspan="1" colspan="1">0.1859</td></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">60 (42&#x02013;65)</td><td rowspan="1" colspan="1">63 (51&#x02013;69)</td><td rowspan="1" colspan="1">0.3344</td></tr><tr><td rowspan="1" colspan="1">Multi-organ, n (%)</td><td rowspan="1" colspan="1">4 (57)</td><td rowspan="1" colspan="1">33 (82.5)</td><td rowspan="1" colspan="1">0.3763</td></tr><tr><td rowspan="1" colspan="1">Malignancy, n (%)</td><td rowspan="1" colspan="1">4 (57)</td><td rowspan="1" colspan="1">15 (34)</td><td rowspan="1" colspan="1">0.4016</td></tr><tr><td rowspan="1" colspan="1">Major HPB surgery, n (%)</td><td rowspan="1" colspan="1">4 (57)</td><td rowspan="1" colspan="1">13 (29.5)</td><td rowspan="1" colspan="1">0.2033</td></tr><tr><td rowspan="1" colspan="1">Bilirubin (&#x003bc;mol/L)</td><td rowspan="1" colspan="1">92 (29&#x02013;123)</td><td rowspan="1" colspan="1">56 (33&#x02013;143)</td><td rowspan="1" colspan="1">0.7346</td></tr><tr><td rowspan="1" colspan="1">ALP (IU/L)</td><td rowspan="1" colspan="1">445 (322&#x02013;560)</td><td rowspan="1" colspan="1">354 (242&#x02013;638)</td><td rowspan="1" colspan="1">0.6964</td></tr><tr><td rowspan="1" colspan="1">gGT (IU/L)</td><td rowspan="1" colspan="1">362 (192&#x02013;887)</td><td rowspan="1" colspan="1">508 (265&#x02013;816)</td><td rowspan="1" colspan="1">0.6207</td></tr><tr><td rowspan="1" colspan="1">AST (IU/L)</td><td rowspan="1" colspan="1">93 (51&#x02013;167)</td><td rowspan="1" colspan="1">83 (69&#x02013;195)</td><td rowspan="1" colspan="1">0.6058</td></tr><tr><td rowspan="1" colspan="1">ALT (IU/L)</td><td rowspan="1" colspan="1">148 (97&#x02013;234)</td><td rowspan="1" colspan="1">117 (79&#x02013;330)</td><td rowspan="1" colspan="1">0.5542</td></tr><tr><td rowspan="1" colspan="1">CA19.9 (kU/L)</td><td rowspan="1" colspan="1">191 (183&#x02013;220)</td><td rowspan="1" colspan="1">73 (24&#x02013;239)</td><td rowspan="1" colspan="1">0.6465</td></tr><tr><td rowspan="1" colspan="1">CRP (mg/L)</td><td rowspan="1" colspan="1">30 (23&#x02013;83)</td><td rowspan="1" colspan="1">11 (5&#x02013;31)</td><td rowspan="1" colspan="1">0.9766</td></tr><tr><td rowspan="1" colspan="1">ESR (mm/h)</td><td rowspan="1" colspan="1">69 (47&#x02013;88)</td><td rowspan="1" colspan="1">44 (20&#x02013;71)</td><td rowspan="1" colspan="1">0.2135</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140089376145984"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/table/tbl1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="tspara0015"><p class="p p-first-last">Levels of significance: <em>p</em> &#x0003c; 0.05 was seen as significant. For categorical data (sex, multi-organ, malignancy, major HPB surgery) Fisher&#x02019;s exact test was performed. For numerical data (age, bilirubin, ALP, gGT, AST, ALT, CA19.9, CRP, ESR) an unpaired <em>t</em> test was performed.</p></div><div id="tspara0020"><p class="p p-first-last">ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CA19.9, cancer antigen 19.9; CRP, c-reactive protein; ESR, erythrocyte sedimentation rate; gGT, gamma-glutamyl transferase; HPB, hepatopancreatobiliary; IRC, IgG4-related cholangitis.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl2"><h3>Table&#x000a0;2</h3><!--caption a7--><div class="caption"><p>Characteristics of individuals with IRC positive for anti-laminin 511-E8 autoantibodies.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">#49</th><th align="left" rowspan="1" colspan="1">#42</th><th align="left" rowspan="1" colspan="1">#51</th><th align="left" rowspan="1" colspan="1">#74</th><th align="left" rowspan="1" colspan="1">#268</th><th align="left" rowspan="1" colspan="1">#288</th><th align="left" rowspan="1" colspan="1">#57</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age at onset (years)</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">74</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1">34</td></tr><tr><td rowspan="1" colspan="1">Time to diagnosis (months)</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">93</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">360</td></tr><tr><td rowspan="1" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">F</td><td align="left" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">F</td></tr><tr><td rowspan="1" colspan="1">Profession</td><td align="left" rowspan="1" colspan="1">Driver petrochemical company</td><td align="left" rowspan="1" colspan="1">Truck driver</td><td align="left" rowspan="1" colspan="1">Military service, limousine driver</td><td align="left" rowspan="1" colspan="1">Beautician, car sales</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">Construction worker</td><td align="left" rowspan="1" colspan="1">Cleaner</td></tr><tr><td rowspan="1" colspan="1">Organ involvement</td><td align="left" rowspan="1" colspan="1">IRC<br />AIP<br />Salivary glands</td><td align="left" rowspan="1" colspan="1">IRC<br />AIP<br />Kidney</td><td align="left" rowspan="1" colspan="1">IRC</td><td align="left" rowspan="1" colspan="1">IRC</td><td align="left" rowspan="1" colspan="1">IRC</td><td align="left" rowspan="1" colspan="1">IRC<br />AIP</td><td align="left" rowspan="1" colspan="1">IRC<br />AIP<br />Lung, colon</td></tr><tr><td rowspan="1" colspan="1">Autoantibody positivity</td><td align="left" rowspan="1" colspan="1">Laminin 511-E8</td><td align="left" rowspan="1" colspan="1">Laminin 511-E8<br />Annexin A11<br />Prohibitin 1</td><td align="left" rowspan="1" colspan="1">Laminin 511-E8<br />Prohibitin 1</td><td align="left" rowspan="1" colspan="1">Laminin 511-E8<br />Prohibitin 1</td><td align="left" rowspan="1" colspan="1">Laminin 511-E8<br />Galectin-3<br />Prohibitin 1</td><td align="left" rowspan="1" colspan="1">Laminin 511-E8<br />Prohibitin 1</td><td align="left" rowspan="1" colspan="1">Laminin 511-E8<br />Prohibitin 1<br />Annexin A11</td></tr><tr><td rowspan="1" colspan="1">Surgery</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Hemihepatectomy</td><td align="left" rowspan="1" colspan="1">PPPD<br />Hemihepatectomy</td><td align="left" rowspan="1" colspan="1">Bile duct resection</td><td align="left" rowspan="1" colspan="1">Bile duct resection</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Malignancy</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">CRC 2 years after IgG4-RD onset</td><td align="left" rowspan="1" colspan="1">CCA at diagnosis, 2&#x000d7; recurrence after IRC diagnosis</td><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">Sigmoid carcinoma 6 years prior to IgG4-RD onset</td><td align="left" rowspan="1" colspan="1">CCA 27 years after first manifestation</td></tr><tr><td rowspan="1" colspan="1">Therapy</td><td align="left" rowspan="1" colspan="1">ERCP with stent placement<br />Prednisolone</td><td align="left" rowspan="1" colspan="1">Spontaneous improvement</td><td align="left" rowspan="1" colspan="1">UDCA</td><td align="left" rowspan="1" colspan="1">Prednisolone<br />Azathioprine/6-Thioguanine<br />UDCA</td><td align="left" rowspan="1" colspan="1">No therapy</td><td align="left" rowspan="1" colspan="1">ERCP with stent placement<br />Prednisolone<br />6-Thioguanine<br />UDCA</td><td align="left" rowspan="1" colspan="1">Stent placement<br />UDCA<br />Prednisolone</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140089373690496"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/table/tbl2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.u.c.b.b.m.d.a"><p class="p p-first-last">AIP, type 1 autoimmune pancreatitis; CCA, cholangiocarcinoma; CRC, colorectal carcinoma; ERCP, endoscopic retrograde cholangiopancreaticography; IRC, IgG4-related cholangitis; PPPD, pylorus-preserving pancreatoduodenectomy; PSC, primary sclerosing cholangitis; UDCA, ursodeoxycholic acid.</p></div></div></div></div><div id="sec3.2" class="sec"><h3 id="sec3.2title">Laminin 511 constituents are highly expressed in models of human cholangiocytes</h3><p id="p0140" class="p p-first">As cholangiocytes are the main cell type affected in IRC, laminin 511 expression was assessed in human control extrahepatic bile duct tissue by immunofluorescence (<a href="/pmc/articles/PMC10959701/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>A). A sharp peribiliary staining pattern was observed. To differentiate the cellular origin of peribiliary laminin staining in cholangiocytes <em>vs.</em> periductal fibroblasts, gene constituent expression of laminin was studied in human cholangiocytes and compared with periductal fibroblasts that also could contribute to laminin 511 production. The laminin 511 gene constituent expression appeared highest in the cholangiocyte population (<a href="/pmc/articles/PMC10959701/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>A). Additionally, on a protein level, LAMA5 expression was negligibly low in activated myofibroblasts compared with cholangiocytes (<a href="#appsec1" rid="appsec1" class=" sec">Fig.&#x000a0;S2</a>). To further determine the cholangiocellular expression of <em>LAMA5</em>, <em>LAMB1,</em> and <em>LAMC1</em>, two types of human cholangiocyte organoids and human H69 cholangiocytes were assessed. In all datasets, a cholangiocyte phenotype was demonstrated by high expression of cholangiocellular markers <em>EPCAM</em> (epithelial cell adhesion molecule) and <em>KRT19</em> (cytokeratin 19), whereas expression of the&#x000a0;hepatocyte markers <em>ALB</em> (albumin) and <em>ASGR1</em> (asialoglycoprotein receptor 1) was low. The three genetic laminin 511 constituents <em>LAMA5, LAMB1, LAMC1</em> showed high expression across all types of cholangiocyte organoids and human H69 cholangiocytes (<a href="/pmc/articles/PMC10959701/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>A). Thus, laminin is highly expressed in human cholangiocytes, but not periductal fibroblasts.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig2" co-legend-rid="lgnd_fig2"><a href="/pmc/articles/PMC10959701/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140089373959840"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10959701_gr2.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10959701/bin/gr2.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140089373959840"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/figure/fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig2"><div><a class="figpopup" href="/pmc/articles/PMC10959701/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2">Fig.&#x000a0;2</a></div><!--caption a7--><div class="caption"><p>Laminin 511 constituents are expressed in various human cholangiocyte models.</p><p>(A) Laminin 511 immunofluorescent staining in human hepatobiliary control tissue discloses a sharp peribiliary staining pattern (scale bar&#x000a0;= 10&#x000a0;&#x003bc;m). Left heatmap represents laminin 511 gene constituent expression in cholangiocyte, hepatocyte, and periductal fibroblast clusters from human liver. Right heatmaps demonstrate expression levels of laminin 511 constituents in two different human cholangioid models and H69 cholangiocytes. Establishment of (B) LAMA5 (400&#x000a0;kDa), (C) LAMB1 (198&#x000a0;kDa), and (D) LAMC1 (178&#x000a0;kDa) shRNA knockdown H69 cholangiocytes. Quantification of (E) LAMA5, (F) LAMB1, and (G) LAMC1 protein levels normalized by ATP1A1 (112&#x000a0;kDa), (nine cell samples from n&#x000a0;= 3 independent experiments). Data are represented as mean with standard deviation. Levels of significance: (E&#x02013;G) &#x02217;&#x02217;&#x02217;&#x02217;<em>p</em> &#x0003c;0.0001; unpaired <em>t</em> test. A.U., arbitrary units; Control, shRNA control; ECO/ICO, extra-/intrahepatic cholangiocyte organoids; KD, knockdown; <em>LAMA5</em>, laminin alpha 5 chain; <em>LAMB1</em>, laminin beta 1 chain; <em>LAMC1</em>, laminin gamma 1 chain.</p></div></div></div><p id="p0145" class="p p-last">To further investigate the physiological role of laminin 511 in cholangiocytes, stable knockdown cell lines for <em>LAMA5</em>, <em>LAMB1,</em> and <em>LAMC1</em> were generated in human H69 cholangiocytes by lentiviral shRNA transduction. Expression of laminin 511 constituents and their respective knockdown were demonstrated on the protein level by Western blot; <em>LAMA5</em> (83% knockdown), <em>LAMB1</em> (76% knockdown), and <em>LAMC1</em> (90% knockdown) (<a href="/pmc/articles/PMC10959701/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>B&#x02013;G) and on mRNA level by RT-qPCR (<a href="#appsec1" rid="appsec1" class=" sec">Fig.&#x000a0;S3</a>).</p></div><div id="sec3.3" class="sec"><h3 id="sec3.3title">Recombinant laminin 511-E8 leads to transcriptional changes in cholangiocytes relating to barrier function and inflammation</h3><p id="p0150" class="p p-first-last">To examine the endogenous roles of laminin 511 in human cholangiocytes, RNA sequencing was performed after treatment of human H69 cholangiocytes with recombinant laminin 511-E8. Initial multidimensional scaling (MDS) showed that recombinant laminin 511-E8 treatment clustered the samples together, whereas more spread was observed in the untreated cholangiocytes (<a href="/pmc/articles/PMC10959701/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Fig.&#x000a0;3</span></a>A). Gene set enrichment analysis showed that processes related to extracellular matrix, cell polarity, barrier function, and inflammation demonstrated enrichment after recombinant laminin 511-E8 treatment (<a href="/pmc/articles/PMC10959701/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Fig.&#x000a0;3</span></a>B&#x02013;D). Only a limited number of secretory genes were differentially expressed (<a href="/pmc/articles/PMC10959701/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Fig.&#x000a0;3</span></a>E). To further investigate a potential relation between laminin 511 and secretion, H69 cholangiocytes were treated with a higher dose (2&#x000a0;&#x003bc;g/cm<sup>2</sup>) of recombinant laminin 511-E8, and gene expression was studied by RT-qPCR. Increased expression was found in the secretory genes <em>CA2</em> and <em>SLC4A2</em>, while a decrease in <em>CHP1,</em> an essential co-factor of <em>SLC9A1</em>, was seen (<a href="/pmc/articles/PMC10959701/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Fig.&#x000a0;3</span></a>F). Thus, altered gene expression after recombinant laminin 511-E8 treatment implicated roles for laminin 511 in cholangiocellular barrier function, inflammation, and secretory processes.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig3" co-legend-rid="lgnd_fig3"><a href="/pmc/articles/PMC10959701/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140089339531360"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10959701_gr3.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10959701/bin/gr3.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140089339531360"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/figure/fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig3"><div><a class="figpopup" href="/pmc/articles/PMC10959701/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3">Fig.&#x000a0;3</a></div><!--caption a7--><div class="caption"><p>Recombinant laminin 511-E8 treatment transcriptionally alters genes involved in cholangiocellular barrier function, inflammation, and secretion.</p><p>(A) MDS plot of recombinant laminin 511-E8 (0.25&#x000a0;&#x003bc;g/cm<sup>2</sup>) treated and untreated control cholangiocytes. (B) GSEA displaying enriched gene sets from MSigDB. Heatmaps of (C) differentially expressed genes relating to cell barrier function, (D) inflammation, and (E) secretion. (F) RT-qPCR target genes related to secretion after high-dose (2&#x000a0;&#x003bc;g/cm<sup>2</sup>) recombinant laminin 511-E8. Heatmaps show Log2 transformed z-scored expression values. Levels of significance: (B) -log10 (<em>p</em> value) &#x0003e;1.3 was seen as significant. (F) ns&#x000a0;= not significant, &#x02217;<em>p</em> &#x0003c;0.05, &#x02217;&#x02217;<em>p</em> &#x0003c;0.01; unpaired <em>t</em> test. BP, biological process; CC, cellular component; Ctrl, control; FC, fold change; GO, gene ontology; GSEA, gene set enrichment analysis; MDS, multidimensional scaling; MF, molecular function; MSigDB, molecular signatures database; N0, starting concentration.</p></div></div></div></div><div id="sec3.4" class="sec"><h3 id="sec3.4title">Knockdown of laminin 511 constituents increases toxic bile acid permeation and vulnerability to bile acid-induced apoptosis</h3><p id="p0155" class="p p-first">As secretory proteins are involved in cholangiocellular protection against toxic hydrophobic bile acids, we investigated whether knockdown of the laminin 511 constituents would render cholangiocytes vulnerable to toxic bile acids.</p><p id="p0160">Bile acid permeation assays demonstrated that <em>LAMB1</em> and <em>LAMC1</em> knockdown cholangiocytes showed an increased GCDC permeation at 4, 16, and 64&#x000a0;min, whereas <em>LAMA5</em> knockdown cholangiocytes only showed an increased toxic bile acid permeation at 64&#x000a0;min (<a href="/pmc/articles/PMC10959701/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig.&#x000a0;4</span></a>A&#x02013;F). To gain further insight into a potentially altered pH homeostasis induced by the knockdown of laminin 511 constituents, intracellular pH (pHi) measurements were performed. These assays indicated that <em>LAMA5</em>, <em>LAMB1,</em> and <em>LAMC1</em> knockdown cholangiocytes had a lower pHi compared to control H69 cholangiocytes (<a href="#appsec1" rid="appsec1" class=" sec">Fig.&#x000a0;S4, Table S3</a>). Baseline intracellular pH tended to decrease in <em>LAMA5</em> knockdown cholangiocytes and decreased in <em>LAMB1</em> and <em>LAMC1</em> cholangiocytes.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig4" co-legend-rid="lgnd_fig4"><a href="/pmc/articles/PMC10959701/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140089338314640"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10959701_gr4.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10959701/bin/gr4.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140089338314640"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/figure/fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig4"><div><a class="figpopup" href="/pmc/articles/PMC10959701/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4">Fig.&#x000a0;4</a></div><!--caption a7--><div class="caption"><p>Knockdown of laminin 511 constituents increases toxic bile acid permeation and vulnerability to bile acid-induced apoptosis.</p><p><sup>3</sup>H-GCDC permeation assay in control, (A) <em>LAMA5</em>, (B) <em>LAMB1</em>, and (C) <em>LAMC1</em> knockdown cholangiocytes (representative experiment of n&#x000a0;= 3). Relative quantification of <sup>3</sup>H-GCDC permeation per timepoint in control, (D) <em>LAMA5</em>, (E) <em>LAMB1</em>, and (F) <em>LAMC1</em> knockdown cholangiocytes (seven to nine samples from n&#x000a0;= 3 independent experiments). GCDC-induced Caspase-3/7 activity in control (G) <em>LAMA5</em>, (H) <em>LAMB1</em>, and (I) <em>LAMC1</em> knockdown cholangiocytes (nine samples from n&#x000a0;= 3 independent experiments). Data are represented as mean with standard deviation. Levels of significance: (D&#x02013;F) ns&#x000a0;= not significant, &#x02217;<em>p</em> &#x0003c;0.05, &#x02217;&#x02217;<em>p</em> &#x0003c;0.01, &#x02217;&#x02217;&#x02217;&#x02217;<em>p</em> &#x0003c;0.0001; unpaired t-test. (G&#x02013;I) ns&#x000a0;= not significant, &#x02217;&#x02217;<em>p</em> &#x0003c;0.01, &#x02217;&#x02217;&#x02217;<em>p</em> &#x0003c;0.001; unpaired <em>t</em> test. Control, shRNA control; DPMI, disintegrations per minute; GCDC, glycochenodeoxycholic acid; KD, knockdown; <em>LAMA5</em>, laminin alpha 5 chain; <em>LAMB1</em>, laminin beta 1 chain; <em>LAMC1</em>, laminin gamma 1 chain.</p></div></div></div><p id="p0165" class="p p-last">The increased permeation of hydrophobic bile acids is expected to result in an increased rate of apoptosis. Caspase-3/7 assays were performed in <em>LAMA5, LAMB1,</em> and <em>LAMC1</em> knockdown cholangiocytes after exposure to GCDC and Raptinal as a positive control for apoptosis induction. Increased apoptosis was seen in the <em>LAMB1</em> and <em>LAMC1</em> knockdown cholangiocytes, but not in the <em>LAMA5</em> knockdown cholangiocytes (<a href="/pmc/articles/PMC10959701/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig.&#x000a0;4</span></a>G&#x02013;I). The <em>LAMA5</em> knockdown cholangiocytes also showed the smallest alterations in bile acid permeation and baseline pHi. Thus, knockdown of laminin 511 constituents renders cholangiocytes vulnerable to toxic bile acids.</p></div><div id="sec3.5" class="sec"><h3 id="sec3.5title">Recombinant laminin 511-E8 lowers toxic bile acid permeation and dose-dependently protects against bile acid-induced apoptosis</h3><p id="p0170" class="p p-first">As a parallel approach to study the role of laminin 511 in human cholangiocytes, cholangiocyte susceptibility to bile acid toxicity was assessed after recombinant laminin 511-E8 treatment.</p><p id="p0175" class="p p-last">Recombinant laminin 511-E8 treatment reduced GCDC permeation into H69 cholangiocytes at 1, 4, 16, and 64&#x000a0;min (<a href="/pmc/articles/PMC10959701/figure/fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig5" rid-ob="ob-fig5" co-legend-rid="lgnd_fig5"><span>Fig.&#x000a0;5</span></a>A and B). Recombinant laminin 511-E8 lowered baseline pHi (<a href="#appsec1" rid="appsec1" class=" sec">Fig.&#x000a0;S5, Table S3</a>). Furthermore, recombinant laminin 511-E8 dose-dependently alleviated GCDC-induced apoptosis (<a href="/pmc/articles/PMC10959701/figure/fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig5" rid-ob="ob-fig5" co-legend-rid="lgnd_fig5"><span>Fig.&#x000a0;5</span></a>C). Thus, recombinant laminin 511-E8 treatment protects cholangiocytes against toxic bile acid permeation and bile acid-induced apoptosis.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig5" co-legend-rid="lgnd_fig5"><a href="/pmc/articles/PMC10959701/figure/fig5/" target="figure" rid-figpopup="fig5" rid-ob="ob-fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140089334429264"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10959701_gr5.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10959701/bin/gr5.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140089334429264"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/figure/fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig5"><div><a class="figpopup" href="/pmc/articles/PMC10959701/figure/fig5/" target="figure" rid-figpopup="fig5" rid-ob="ob-fig5">Fig.&#x000a0;5</a></div><!--caption a7--><div class="caption"><p>Recombinant laminin 511-E8 lowers toxic bile acid permeation and dose-dependently alleviates bile acid-induced apoptosis.</p><p>(A) <sup>3</sup>H-GCDC permeation assay in control and recombinant laminin 511-E8 treated H69 cholangiocytes (representative experiment of n&#x000a0;= 3). Relative quantification of <sup>3</sup>H-GCDC permeation at (B) 1&#x000a0;min, 4&#x000a0;min, 16&#x000a0;min, 64&#x000a0;min in control and recombinant laminin 511-E8 treated H69 cholangiocytes (eight to nine samples from n&#x000a0;= 3 independent experiments). (C) GCDC-induced Caspase-3/7 activity in WT and recombinant laminin 511-E8 treated H69 cholangiocytes (nine samples from n&#x000a0;= 3 independent experiments). Data are represented as mean with standard deviation. Levels of significance: (B) &#x02217;&#x02217;<em>p</em> &#x0003c;0.01, &#x02217;&#x02217;&#x02217;<em>p</em> &#x0003c;0.001, &#x02217;&#x02217;&#x02217;&#x02217;<em>p</em> &#x0003c;0.0001; unpaired <em>t</em> test. (C) ns&#x000a0;= not significant, &#x02217;<em>p</em> &#x0003c;0.05, &#x02217;&#x02217;<em>p</em> &#x0003c;0.01; one-way ANOVA. Control, shRNA control; DPMI, disintegrations per minute; GCDC, glycochenodeoxycholic acid; KD, knockdown; WT, wild type.</p></div></div></div></div><div id="sec3.6" class="sec"><h3 id="sec3.6title">Knockdown of laminin 511 constituents decreases barrier function in human cholangiocytes</h3><p id="p0180" class="p p-first-last">To assess whether laminin 511 is involved in cholangiocellular barrier formation, FITC&#x02013;Dextran permeability assays were performed. <em>LAMA5</em> and <em>LAMC1</em> KD led to an increase in FITC&#x02013;Dextran permeability at all time points, whereas <em>LAMB1</em> KD only demonstrated a trend towards increased FITC&#x02013;Dextran permeation (<a href="/pmc/articles/PMC10959701/figure/fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig6" rid-ob="ob-fig6" co-legend-rid="lgnd_fig6"><span>Fig.&#x000a0;6</span></a>A and B). These data indicate that laminin 511 could play a role in cholangiocellular barrier formation.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig6" co-legend-rid="lgnd_fig6"><a href="/pmc/articles/PMC10959701/figure/fig6/" target="figure" rid-figpopup="fig6" rid-ob="ob-fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140089375978384"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10959701_gr6.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr6.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10959701/bin/gr6.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140089375978384"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/figure/fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig6"><div><a class="figpopup" href="/pmc/articles/PMC10959701/figure/fig6/" target="figure" rid-figpopup="fig6" rid-ob="ob-fig6">Fig.&#x000a0;6</a></div><!--caption a7--><div class="caption"><p>Knockdown of laminin 511 constituents decreases barrier function in human cholangiocytes.</p><p>(A) Kinetics of FITC&#x02013;Dextran permeability assay in <em>LAMA5</em>, <em>LAMB1,</em> and <em>LAMC1</em> knockdown compared with control cholangiocytes (representative experiment of n&#x000a0;= 4). Relative quantification of FITC&#x02013;Dextran permeability assay at (B) 60&#x000a0;min, 120&#x000a0;min, 180&#x000a0;min, and 240&#x000a0;min in <em>LAMA5</em>, <em>LAMB1,</em> and <em>LAMC1</em> knockdown compared with control cholangiocytes (12 samples from n&#x000a0;= 4 independent experiments). Data are represented as mean with standard deviation. Levels of significance: (B) ns&#x000a0;= not significant, &#x02217;&#x02217;<em>p</em> &#x0003c;0.01, &#x02217;&#x02217;&#x02217;&#x02217;<em>p</em> &#x0003c;0.0001; one-way ANOVA. Control, shRNA control; FITC, fluorescein isothiocyanate; KD, knockdown; <em>LAMB1</em>, laminin beta 1 chain; <em>LAMC1</em>, laminin gamma 1 chain.</p></div></div></div></div><div id="sec3.7" class="sec"><h3 id="sec3.7title">Recombinant laminin 511-E8 enhances barrier function of human cholangiocytes and protects from T lymphocyte-induced barrier dysfunction</h3><p id="p0185" class="p p-first">As a parallel approach, the effect of recombinant laminin 511-E8 on barrier function was assessed. Recombinant laminin 511-E8 significantly reduced FITC&#x02013;Dextran permeation (<a href="/pmc/articles/PMC10959701/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Fig.&#x000a0;7</span></a>A and B).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig7" co-legend-rid="lgnd_fig7"><a href="/pmc/articles/PMC10959701/figure/fig7/" target="figure" rid-figpopup="fig7" rid-ob="ob-fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140089375968112"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10959701_gr7.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr7.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10959701/bin/gr7.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140089375968112"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/figure/fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig7"><div><a class="figpopup" href="/pmc/articles/PMC10959701/figure/fig7/" target="figure" rid-figpopup="fig7" rid-ob="ob-fig7">Fig.&#x000a0;7</a></div><!--caption a7--><div class="caption"><p>Recombinant laminin 511-E8 enhances cholangiocellular barrier function and protects against T lymphocyte-induced barrier dysfunction.</p><p>(A) Kinetics of FITC&#x02013;Dextran permeability assay in cholangiocytes treated with recombinant laminin 511-E8 compared with BSA control coating (representative experiment of n&#x000a0;= 4). Relative quantification of FITC&#x02013;Dextran permeability assay at (B) 60&#x000a0;min, 120&#x000a0;min, 180&#x000a0;min, and 240&#x000a0;min in cholangiocytes treated with recombinant laminin 511-E8 compared with BSA control coating (20 samples from n&#x000a0;= 4 independent experiments). (C) Kinetics of FITC-Dextran permeability assay in co-culture set-up of activated T lymphocytes with H69 cholangiocytes (representative experiment of n=3). Relative quantification of FITC&#x02013;Dextran permeability assay at (D) 60&#x000a0;min, 120&#x000a0;min, 180&#x000a0;min, and 240&#x000a0;min in co-culture set-up (eight samples from n&#x000a0;= 3 independent experiments). Data are represented as mean with standard deviation. Levels of significance: (B) &#x02217;&#x02217;&#x02217;&#x02217;<em>p</em>&#x000a0;= &#x0003c;0.0001; unpaired <em>t</em> test. (D) &#x02217;&#x02217;<em>p</em> &#x0003c;0.01, &#x02217;&#x02217;&#x02217;<em>p</em> &#x0003c;0.001, &#x02217;&#x02217;&#x02217;&#x02217;<em>p</em> &#x0003c;0.0001; one-way ANOVA. BSA, bovine serum albumin; FITC, fluorescein isothiocyanate.</p></div></div></div><p id="p0190" class="p p-last">To further investigate the role of laminin 511-E8 in the setting of inflammation, H69 cholangiocytes were co-cultured with activated T lymphocytes (<a href="/pmc/articles/PMC10959701/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Fig.&#x000a0;7</span></a>C). Co-culture of H69 cholangiocytes with activated T lymphocytes resulted in an increased FITC-Dextran permeability (<a href="/pmc/articles/PMC10959701/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Fig.&#x000a0;7</span></a>D, gray <em>vs.</em> red). Strikingly, when the H69 monolayer was in basolateral contact with recombinant laminin 511-E8, cholangiocytes were protected from the T lymphocyte-induced barrier dysfunction (<a href="/pmc/articles/PMC10959701/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Fig.&#x000a0;7</span></a>D, red <em>vs.</em> blue). Notably, the co-culture condition with laminin 511-E8 coating maintained the barrier integrity at the same level as the single H69 cholangiocyte culture condition with laminin 511-E8 coating (<a href="/pmc/articles/PMC10959701/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Fig.&#x000a0;7</span></a>D, blue and green). These findings indicate that laminin 511-E8 improves the cholangiocellular barrier function and prevents T lymphocyte-induced barrier dysfunction.</p></div><div id="sec3.8" class="sec sec-last"><h3 id="sec3.8title">Laminin 511 and claudin 1 staining may be altered in extrahepatic bile ducts of anti-laminin 511-E8 positive individuals with IRC</h3><p id="p0195" class="p p-first">To investigate the expression and localization of laminin 511 in individuals with IgG4-related cholangitis, laminin 511 expression was assessed by immunofluorescence in extrahepatic bile duct tissue from available resection specimens of controls and patients who were anti-laminin 511-E8 positive. In healthy control tissue, all bile ducts showed a clear basolateral laminin 511 staining (<a href="/pmc/articles/PMC10959701/figure/fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig8" rid-ob="ob-fig8" co-legend-rid="lgnd_fig8"><span>Fig.&#x000a0;8</span></a>, top panels). In one patient with IRC who was anti-laminin 511-E8 positive (#268), a similar tracing was seen but laminin 511 staining appeared fainter. In the other patient with IRC who was anti-laminin 511-E8 positive (#57) an altered staining pattern was observed with a clear loss of basolateral laminin 511 localization.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig8" co-legend-rid="lgnd_fig8"><a href="/pmc/articles/PMC10959701/figure/fig8/" target="figure" rid-figpopup="fig8" rid-ob="ob-fig8"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140089337934992"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10959701_gr8.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr8.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10959701/bin/gr8.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140089337934992"><a target="object" rel="noopener" href="/pmc/articles/PMC10959701/figure/fig8/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig8"><div><a class="figpopup" href="/pmc/articles/PMC10959701/figure/fig8/" target="figure" rid-figpopup="fig8" rid-ob="ob-fig8">Fig.&#x000a0;8</a></div><!--caption a7--><div class="caption"><p>Laminin 511 and claudin 1 staining may be altered in extrahepatic bile ducts of patients with IRC who were anti-laminin 511-E8 positive.</p><p>Immunofluorescent staining of (top panels) laminin 511 and (bottom panels) claudin 1 alone (green) and as an overlay with cytokeratin 7 (magenta) and Hoechst (blue) in one control and two patients with IRC who were anti-laminin 511-E8 positive (representative images of three fields per condition, <a href="#appsec1" rid="appsec1" class=" sec">Fig.&#x000a0;S6</a> for all fields). Scale bar&#x000a0;= 10&#x000a0;&#x003bc;m. CTRL, control; PT, patient.</p></div></div></div><p id="p0200" class="p p-last">Subsequently, extrahepatic bile duct tissue was stained for the tight junction protein claudin 1. Compared with control tissue, one patient with IRC who was anti-laminin 511-E8 positive (#268) showed a fainter and disrupted claudin 1 staining (<a href="/pmc/articles/PMC10959701/figure/fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig8" rid-ob="ob-fig8" co-legend-rid="lgnd_fig8"><span>Fig.&#x000a0;8</span></a>, bottom panels). In the other patient with IRC who was anti-laminin 511-E8 positive (#57) a clear claudin 1 staining was observed. However, the localization of claudin 1 appeared altered compared with control tissue (as indicated by a higher degree of cytokeratin 7/claudin 1 overlap). All imaged fields can be found in <a href="#appsec1" rid="appsec1" class=" sec">Fig.&#x000a0;S6</a>.</p></div></div><div id="sec4" class="tsec sec"><h2 class="head no_bottom_margin" id="sec4title">Discussion</h2><p id="p0205" class="p p-first">The present study is the first to establish that the heterotrimeric extracellular matrix protein laminin 511-E8 is an autoantigen in a subset of patients with IRC. In addition, the present study unravels physiological roles of laminin 511 in human cholangiocytes, the target cells of the immune attack in IRC. Our data indicate that laminin 511 stabilizes cholangiocellular barrier function and protects human cholangiocytes against T lymphocyte-induced barrier dysfunction, toxic bile acid permeation and bile acid-induced apoptosis.</p><p id="p0210">Autoantibodies against laminin 511-E8 were detected in 13.5% of patients with IRC and not in patients with PSC or CCA. Four out of seven patients positive for laminin 511-E8 autoantibodies had a malignancy. This is different from the first report of autoantibodies against laminin 511-E8 in type I AIP where none of the affected individuals with anti-laminin 511-E8 autoantibodies had a malignancy.<a href="#bib8" rid="bib8" class=" bibr popnode"><sup>8</sup></a> The percentage of individuals positive for anti-laminin 511-E8 autoantibodies had been higher in the cohort with type I AIP (51%) than in our IRC cohort (13.5%). This difference could potentially be explained by differences in organ manifestations (pancreas <em>vs.</em> bile ducts), the genetic background (Japanese <em>vs.</em> Caucasian) and/or environmental risk factors between the two cohorts, but remains unclear at present.</p><p id="p0215">Our experimental data support a protective role of laminin 511 for human cholangiocytes. RNA sequencing implicated laminin 511 to be involved in processes of (i) secretion, (ii) barrier function, and (iii) inflammation. In our RNA sequencing dataset, we were not able to identify driving genes because of the small fold changes after recombinant laminin 511-E8 treatment at 0.25&#x000a0;&#x003bc;g/cm<sup>2</sup>. An explanation could be the degree of variance observed in the MDS plot for untreated H69 cholangiocytes, whereas treatment with laminin 511-E8 clustered the cholangiocytes more closely together. Additionally, in previous studies, higher concentrations of recombinant laminin 511-E8 led to differential expression of secretory genes.<a href="#bib15" rid="bib15" class=" bibr popnode"><sup>15</sup></a><sup>,</sup><a href="#bib33" rid="bib33" class=" bibr popnode"><sup>33</sup></a> Indeed, treatment with 2&#x000a0;&#x003bc;g/cm<sup>2</sup> also led to the upregulation of several genes related to secretion in our study (<em>CA2</em>, <em>SLC4A2</em>). These proteins have been proposed as essential components of the secretory machinery in cholangiocytes.<a href="#bib34" rid="bib34" class=" bibr popnode"><sup>34</sup></a> In turn, these secretory pathways have been hypothesized to create an apical alkaline microenvironment &#x02013; the biliary bicarbonate umbrella &#x02013; that protects cholangiocytes against hydrophobic bile acids.<a href="#bib13" rid="bib13" class=" bibr popnode"><sup>13</sup></a><sup>,</sup><a href="#bib14" rid="bib14" class=" bibr popnode"><sup>14</sup></a> Our data in laminin 511 constituent KD or cell lines demonstrating increased bile acid permeation and increased susceptibility to GCDC-induced apoptosis support such a mechanism. In parallel, recombinant laminin 511-E8 treatment lowered toxic bile acid permeation and dose-dependently alleviated GCDC-induced apoptosis. Still, in the present study, the decrease in intracellular pH in both laminin 511 constituent KD cell lines and in recombinant 511-E8 treated cholangiocytes is incompletely understood. This observation can potentially be explained by the fact that (i) knockdown of one laminin 511 constituent also leads to knockdown of other laminin family members<a href="#bib34" rid="bib34" class=" bibr popnode"><sup>34</sup></a> and (ii) compensatory mechanisms could be at play in knockdown cholangiocytes as this is a stable and permanent strategy.<a href="#bib35" rid="bib35" class=" bibr popnode"><sup>35</sup></a><sup>,</sup><a href="#bib36" rid="bib36" class=" bibr popnode"><sup>36</sup></a></p><p id="p0220">Our data demonstrating a protective role of laminin 511 in cholangiocellular barrier function align with a previous report showing an altered expression of barrier proteins in IRC-derived cholangiocytes.<a href="#bib17" rid="bib17" class=" bibr popnode"><sup>17</sup></a> This study reported a downregulation of the tight-junction protein claudin 1 and an upregulation of the paracellular pore protein claudin 2. Notably, we observed an altered claudin 1 staining in extrahepatic bile ducts of two patients positive for anti-laminin 511-E8 autoantibodies (<a href="/pmc/articles/PMC10959701/figure/fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig8" rid-ob="ob-fig8" co-legend-rid="lgnd_fig8"><span>Fig.&#x000a0;8</span></a>). However, definitive conclusions cannot be drawn regarding impaired laminin 511 and claudin 1 expression in IRC, given the limited number of anti-laminin 511-E8-positive individuals with IRC after liver resection available for assessment in our study. In the above-mentioned report,<a href="#bib17" rid="bib17" class=" bibr popnode"><sup>17</sup></a> the downregulation of claudin 1 and upregulation of claudin 2 were related to inflammation and were regulated by IL-4 and IL-13. These cytokines are derived from T cell populations known to be involved in the pathogenesis of IRC.<a href="#bib37" rid="bib37" class=" bibr popnode"><sup>37</sup></a> Notably, in endothelial cells, laminin 511 has been shown to prevent the extravasation of leukocytes and activation of T helper 17 (Th17) cells.<a href="#bib19" rid="bib19" class=" bibr popnode"><sup>19</sup></a><sup>,</sup><a href="#bib20" rid="bib20" class=" bibr popnode"><sup>20</sup></a><sup>,</sup><a href="#bib22" rid="bib22" class=" bibr popnode"><sup>22</sup></a><sup>,</sup><a href="#bib38" rid="bib38" class=" bibr popnode">[38]</a>, <a href="#bib39" rid="bib39" class=" bibr popnode">[39]</a>, <a href="#bib40" rid="bib40" class=" bibr popnode">[40]</a> These reports fit with our RNA sequencing data suggesting a role for laminin 511 in regulating both cholangiocellular barrier function and inflammation. Indeed, our functional experiments demonstrated that laminin 511 constituent knockdown impaired cholangiocellular barrier function whereas recombinant laminin 511-E8 treatment improved cholangiocellular barrier function and prevented T lymphocyte-induced cholangiocellular barrier dysfunction.</p><p id="p0225">It appears possible that autoantibodies directed against laminin 511-E8 could block its protective cholangiocellular functions &#x02013; as those in other secretory organs affected by IgG4-RD.<a href="#bib1" rid="bib1" class=" bibr popnode"><sup>1</sup></a><sup>,</sup><a href="#bib2" rid="bib2" class=" bibr popnode"><sup>2</sup></a> Anti-laminin 511-E8 autoantibodies could potentially contribute to the pathogenesis of IRC by impairing cholangiocellular secretion and barrier function, thereby enhancing the risk of both, T lymphocyte- and bile acid-induced damage. Notably, four out of seven IRC patients with autoantibodies against laminin 511-E8 had IgG4-RD manifestations in other secretory organs that are associated with an impaired barrier function and defective bicarbonate secretion, being the pancreas,<a href="#bib41" rid="bib41" class=" bibr popnode"><sup>41</sup></a><sup>,</sup><a href="#bib42" rid="bib42" class=" bibr popnode"><sup>42</sup></a> salivary glands,<a href="#bib43" rid="bib43" class=" bibr popnode"><sup>43</sup></a><sup>,</sup><a href="#bib44" rid="bib44" class=" bibr popnode"><sup>44</sup></a> kidney,<a href="#bib45" rid="bib45" class=" bibr popnode"><sup>45</sup></a> and colon. This makes it tempting to speculate that a decreased epithelial barrier function with attraction of immune cells and impaired bicarbonate secretion because of dysfunction of laminin 511 by autoantibody binding could potentially be a common systemic pathogenic mechanism in a subset of IgG4-RD patients.</p><p id="p0230" class="p p-last">In conclusion, our study demonstrates that laminin 511-E8 is an autoantigen in a subset of individuals with IRC. Laminin 511 is located in the extracellular matrix of human cholangiocytes where it promotes cholangiocellular barrier function, prevents T lymphocyte-induced cholangiocellular barrier dysfunction, and protects human cholangiocytes against permeation of toxic bile acids and bile acid-induced apoptosis. Future studies will have to assess whether anti-laminin 511 autoantibodies directly contribute to the pathogenesis of IRC in a subset of affected individuals.</p></div><div id="sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="sec5title">Financial support</h2><p id="p0235" class="p p-first-last">This study was supported by a ZonMw Open Competition grant (to UB), a South African PSC patient foundation grant (Stichting AMC Foundation #20837 to UB), a Gastrostart grant of the Netherlands Society of Gastroenterology (NVGE) and the Netherlands Association for the Study of the Liver (NASL) (to DT and RK), and an Amsterdam UMC/AMC PhD Scholarship (to DT). DT, RK, DTo, AJ, and SvdG have nothing to disclose. UB received lecture and consulting fees from Abacus, Behring, GSK and Zambon.</p></div><div id="sec7" class="tsec sec"><h2 class="head no_bottom_margin" id="sec7title">Authors&#x02019; contributions</h2><p id="p0250" class="p p-first-last">Conceived the experiments: DT, RK, SvdG, UB. Performed the experiments: DT, RK, DTo. Analysed the data: DT, RK, DTo, SvdG, UB. Wrote the original draft of the manuscript: DT, RK, UB. Reviewing and editing: all authors. Our RNA sequencing dataset analysis and graphica display: AJ, DT, RK. Approval of the final manuscript: all authors. Funding facilitation: DT, RK, UB.</p></div><div id="sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="sec8title">Data availability statement</h2><p id="p0255" class="p p-first-last">RNA sequencing data were submitted to NCBI Gene Expression Omnibus (GEO) and are freely available under GEO accession number <a id="__tag_1145657179" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE221746" ref="/geo/query/acc.cgi?acc=GSE221746"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE221746","term_id":"221746","extlink":"1"}}</span>GSE221746</a>.</p></div><div id="sec-a.u.h" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.u.htitle">Conflicts of interest</h2><p id="p0240" class="p p-first">The authors declare no conflicts of interest with regard to this work.</p><p id="p0245" class="p p-last">Please refer to the accompanying ICMJE disclosure forms for further details.</p></div><div id="ack0010" class="tsec sec"><h2 class="head no_bottom_margin" id="ack0010title">Acknowledgements</h2><div class="sec"><p id="p0260">We gratefully acknowledge Dr Perry D. Moerland for recommendations on the analysis of datasets obtained from Gene Expression Omnibus (GEO) and Dr Jan Koster for making use of the R2 genomics analysis and visualization platform (<a href="http://r2.amc.nl/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://r2.amc.nl/</a>). We also acknowledge N. Aizarani and D. Gr&#x000fc;n (GEO accession <a id="__tag_1145657177" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE124395" ref="/geo/query/acc.cgi?acc=GSE124395"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE124395","term_id":"124395"}}</span>GSE124395</a>), and F. Roos, H. Wu, M. Verstegen and L. van der Laan (GEO accession <a id="__tag_1145657176" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE156519" ref="/geo/query/acc.cgi?acc=GSE156519"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE156519","term_id":"156519"}}</span>GSE156519</a>) for kindly depositing their RNA sequencing datasets in GEO available to the public. We also acknowledge Prof. Dr Joanne Verheij for support in obtaining extrahepatic bile duct tissue from the Amsterdam UMC HPB Pathology biobank and Esther Vogels for cutting the tissue sections for downstream immunofluorescent staining and imaging. The Graphical abstract was created with BioRender.com.</p></div></div><div id="fn-group-a.v.d" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.v.dtitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="d36e592"><p id="ntpara0010" class="p p-first-last">Author names in bold designate shared co-first authorship.</p></p><p class="fn sec" id="appsec2"><p id="p0270" class="p p-first-last">Supplementary data to this article can be found online at <a href="https://doi.org/10.1016/j.jhepr.2024.101015" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://doi.org/10.1016/j.jhepr.2024.101015</a>.</p></p></div></div><div id="appsec1" class="tsec bk-sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="appsec1title">Supplementary data</h2><!--/article/back/sec/--><p id="p0265" class="p p-first-last">The following are the supplementary data to this article:</p><div class="sec suppmat" id="mmc1"><!--caption a9--><strong>Multimedia component 1:</strong><div class="sup-box half_rhythm" id="media-a.v.b.b.a.b"><a href="/pmc/articles/PMC10959701/bin/mmc1.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(22M, docx)</sup></div></div><div class="sec suppmat" id="mmc2"><!--caption a9--><strong>Multimedia component 2:</strong><div class="sup-box half_rhythm" id="media-a.v.b.b.b.b"><a href="/pmc/articles/PMC10959701/bin/mmc2.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(58K, docx)</sup></div></div><div class="sec suppmat" id="mmc3"><!--caption a9--><strong>Multimedia component 3:</strong><div class="sup-box half_rhythm" id="media-a.v.b.b.c.b"><a href="/pmc/articles/PMC10959701/bin/mmc3.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(460K, pdf)</sup></div></div><div class="sec suppmat" id="mmc4"><!--caption a9--><strong>Multimedia component 4:</strong><div class="sup-box half_rhythm" id="media-a.v.b.b.d.b"><a href="/pmc/articles/PMC10959701/bin/mmc4.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(6.1M, pdf)</sup></div></div><p></p></div><div id="cebib0010" class="tsec sec"><h2 class="head no_bottom_margin" id="cebib0010title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="bib1">1. <span class="element-citation" id="sref1">Katz G., Stone J.H. Clinical perspectives on IgG4-related disease and its classification. <span><span class="ref-journal">Annu Rev Med. </span>2022;<span class="ref-vol">73</span>:545–562.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34669430" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Med&amp;title=Clinical+perspectives+on+IgG4-related+disease+and+its+classification&amp;author=G.+Katz&amp;author=J.H.+Stone&amp;volume=73&amp;publication_year=2022&amp;pages=545-562&amp;pmid=34669430&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib2">2. <span class="element-citation" id="sref2">L&#x000f6;hr J.-M., Vujasinovic M., Rosendahl J., et al. IgG4-related diseases of the digestive tract. <span><span class="ref-journal">Nat Rev Gastroenterol Hepatol. </span>2022;<span class="ref-vol">19</span>:185–197.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34750548" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Gastroenterol+Hepatol&amp;title=IgG4-related+diseases+of+the+digestive+tract&amp;author=J.-M.+L&#x000f6;hr&amp;author=M.+Vujasinovic&amp;author=J.+Rosendahl&amp;volume=19&amp;publication_year=2022&amp;pages=185-197&amp;pmid=34750548&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib3">3. <span class="element-citation" id="sref3">Roos E., Hubers L.M., Coelen R.J.S., et al. IgG4-associated cholangitis in patients resected for presumed perihilar cholangiocarcinoma: a 30-year tertiary care experience. <span><span class="ref-journal">Am J Gastroenterol. </span>2018;<span class="ref-vol">113</span>:765–772.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29549357" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Gastroenterol&amp;title=IgG4-associated+cholangitis+in+patients+resected+for+presumed+perihilar+cholangiocarcinoma:+a+30-year+tertiary+care+experience&amp;author=E.+Roos&amp;author=L.M.+Hubers&amp;author=R.J.S.+Coelen&amp;volume=113&amp;publication_year=2018&amp;pages=765-772&amp;pmid=29549357&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib4">4. <span class="element-citation" id="sref4">Maillette de Buy Wenniger L.J., Doorenspleet M.E., Klarenbeek P.L., et al. Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. <span><span class="ref-journal">Hepatology. </span>2013;<span class="ref-vol">57</span>:2390–2398.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23300096" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Immunoglobulin+G4++clones+identified+by+next-generation+sequencing+dominate+the+B+cell+receptor+repertoire+in+immunoglobulin+G4+associated+cholangitis&amp;author=L.J.+Maillette+de+Buy+Wenniger&amp;author=M.E.+Doorenspleet&amp;author=P.L.+Klarenbeek&amp;volume=57&amp;publication_year=2013&amp;pages=2390-2398&amp;pmid=23300096&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib5">5. <span class="element-citation" id="sref5">Mattoo H., Mahajan V.S., Della-Torre E., et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. <span><span class="ref-journal">J&#x000a0;Allergy Clin Immunol. </span>2014;<span class="ref-vol">134</span>:679–687.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4149918/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24815737" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J&#x000a0;Allergy+Clin+Immunol&amp;title=De+novo+oligoclonal+expansions+of+circulating+plasmablasts+in+active+and+relapsing+IgG4-related+disease&amp;author=H.+Mattoo&amp;author=V.S.+Mahajan&amp;author=E.+Della-Torre&amp;volume=134&amp;publication_year=2014&amp;pages=679-687&amp;pmid=24815737&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib6">6. <span class="element-citation" id="sref6">Wallace Z.S., Mattoo H., Carruthers M., et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. <span><span class="ref-journal">Ann Rheum Dis. </span>2015;<span class="ref-vol">74</span>:190–195.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4656194/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24817416" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum+Dis&amp;title=Plasmablasts+as+a+biomarker+for+IgG4-related+disease,+independent+of+serum+IgG4+concentrations&amp;author=Z.S.+Wallace&amp;author=H.+Mattoo&amp;author=M.+Carruthers&amp;volume=74&amp;publication_year=2015&amp;pages=190-195&amp;pmid=24817416&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib7">7. <span class="element-citation" id="sref7">Hubers L., Vos H., Schuurman A., et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. <span><span class="ref-journal">Gut. </span>2018;<span class="ref-vol">67</span></span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28765476" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Annexin+A11+is+targeted+by+IgG4+and+IgG1+autoantibodies+in+IgG4-related+disease&amp;author=L.+Hubers&amp;author=H.+Vos&amp;author=A.+Schuurman&amp;volume=67&amp;publication_year=2018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib8">8. <span class="element-citation" id="sref8">Shiokawa M., Kodama Y., Sekiguchi K., et al. Laminin 511 is a target antigen in autoimmune pancreatitis. <span><span class="ref-journal">Sci Transl Med. </span>2018;<span class="ref-vol">10</span></span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30089633" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=Laminin+511+is+a+target+antigen+in+autoimmune+pancreatitis&amp;author=M.+Shiokawa&amp;author=Y.+Kodama&amp;author=K.+Sekiguchi&amp;volume=10&amp;publication_year=2018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib9">9. <span class="element-citation" id="sref9">Perugino C.A., AlSalem S.B., Mattoo H., et al. Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. <span><span class="ref-journal">J&#x000a0;Allergy Clin Immunol. </span>2019;<span class="ref-vol">143</span>:736–745.e6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6265117/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29852256" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J&#x000a0;Allergy+Clin+Immunol&amp;title=Identification+of+galectin-3+as+an+autoantigen+in+patients+with+IgG4-related+disease&amp;author=C.A.+Perugino&amp;author=S.B.+AlSalem&amp;author=H.+Mattoo&amp;volume=143&amp;publication_year=2019&amp;pages=736-745.e6&amp;pmid=29852256&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib10">10. <span class="element-citation" id="sref10">Shiokawa M., Kodama Y., Kuriyama K., et al. Pathogenicity of IgG in patients with IgG4-related disease. <span><span class="ref-journal">Gut. </span>2016;<span class="ref-vol">65</span>:1322–1332.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26964842" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Pathogenicity+of+IgG+in+patients+with+IgG4-related+disease&amp;author=M.+Shiokawa&amp;author=Y.+Kodama&amp;author=K.+Kuriyama&amp;volume=65&amp;publication_year=2016&amp;pages=1322-1332&amp;pmid=26964842&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib11">11. <span class="element-citation" id="sref11">Liu H., Perugino C.A., Ghebremichael M., et al. Disease severity linked to increase in autoantibody diversity in IgG4-related disease. <span><span class="ref-journal">Arthritis Rheumatol (Hoboken, NJ) </span>2020;<span class="ref-vol">72</span>:687–693.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7113109/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31612628" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheumatol+(Hoboken,+NJ)&amp;title=Disease+severity+linked+to+increase+in+autoantibody+diversity+in+IgG4-related+disease&amp;author=H.+Liu&amp;author=C.A.+Perugino&amp;author=M.+Ghebremichael&amp;volume=72&amp;publication_year=2020&amp;pages=687-693&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib12">12. <span class="element-citation" id="sref12">Herta T., Kersten R., Chang J.-C., et al. Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection. <span><span class="ref-journal">J&#x000a0;Hepatol. </span>2022;<span class="ref-vol">76</span>:319–331.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10804347/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34718050" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J&#x000a0;Hepatol&amp;title=Role+of+the+IgG4-related+cholangitis+autoantigen+annexin+A11+in+cholangiocyte+protection&amp;author=T.+Herta&amp;author=R.+Kersten&amp;author=J.-C.+Chang&amp;volume=76&amp;publication_year=2022&amp;pages=319-331&amp;pmid=34718050&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib13">13. <span class="element-citation" id="sref13">Hohenester S., Maillette de Buy Wenniger L.J., Paulusma C.C., et al. A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. <span><span class="ref-journal">Hepatology. </span>2012;<span class="ref-vol">55</span>:173–183.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21932391" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=A+biliary+HCO3-+umbrella+constitutes+a+protective+mechanism+against+bile+acid-induced+injury+in+human+cholangiocytes&amp;author=S.+Hohenester&amp;author=L.J.+Maillette+de+Buy+Wenniger&amp;author=C.C.+Paulusma&amp;volume=55&amp;publication_year=2012&amp;pages=173-183&amp;pmid=21932391&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib14">14. <span class="element-citation" id="sref14">Beuers U., Hohenester S., Maillette de Buy Wenniger L.J., et al. The biliary&#x000a0;HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. <span><span class="ref-journal">Hepatology. </span>2010;<span class="ref-vol">52</span>:1489–1496.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20721884" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=The+biliary&#x000a0;HCO(3)(-)+umbrella:+a+unifying+hypothesis+on+pathogenetic+and+therapeutic+aspects+of+fibrosing+cholangiopathies&amp;author=U.+Beuers&amp;author=S.+Hohenester&amp;author=L.J.+Maillette+de+Buy+Wenniger&amp;volume=52&amp;publication_year=2010&amp;pages=1489-1496&amp;pmid=20721884&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib15">15. <span class="element-citation" id="sref15">Takayama K., Mitani S., Nagamoto Y., et al. Laminin 411 and 511 promote the cholangiocyte differentiation of human induced pluripotent stem cells. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2016;<span class="ref-vol">474</span>:91–96.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27103433" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Laminin+411+and+511+promote+the+cholangiocyte+differentiation+of+human+induced+pluripotent+stem+cells&amp;author=K.+Takayama&amp;author=S.+Mitani&amp;author=Y.+Nagamoto&amp;volume=474&amp;publication_year=2016&amp;pages=91-96&amp;pmid=27103433&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib16">16. <span class="element-citation" id="sref16">Aumailley M. The laminin family. <span><span class="ref-journal">Cell Adh Migr. </span>2013;<span class="ref-vol">7</span>:48–55.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3544786/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23263632" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Adh+Migr&amp;title=The+laminin+family&amp;author=M.+Aumailley&amp;volume=7&amp;publication_year=2013&amp;pages=48-55&amp;pmid=23263632&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib17">17. <span class="element-citation" id="sref17">M&#x000fc;ller T., Beutler C., Pic&#x000f3; A.H., et al. Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier. <span><span class="ref-journal">Gastroenterology. </span>2013;<span class="ref-vol">144</span>:1116–1128.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23391819" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Increased+T-helper+2+cytokines+in+bile+from+patients+with+IgG4-related+cholangitis+disrupt+the+tight+junction-associated+biliary+epithelial+cell+barrier&amp;author=T.+M&#x000fc;ller&amp;author=C.+Beutler&amp;author=A.H.+Pic&#x000f3;&amp;volume=144&amp;publication_year=2013&amp;pages=1116-1128&amp;pmid=23391819&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib18">18. <span class="element-citation" id="sref18">Mattoo H., Stone J.H., Pillai S. Clonally expanded cytotoxic CD4+ T cells&#x000a0;and&#x000a0;the pathogenesis of IgG4-related disease. <span><span class="ref-journal">Autoimmunity. </span>2017;<span class="ref-vol">50</span>:19–24.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5880292/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28166682" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Autoimmunity&amp;title=Clonally+expanded+cytotoxic+CD4++T+cells&#x000a0;and&#x000a0;the+pathogenesis+of+IgG4-related+disease&amp;author=H.+Mattoo&amp;author=J.H.+Stone&amp;author=S.+Pillai&amp;volume=50&amp;publication_year=2017&amp;pages=19-24&amp;pmid=28166682&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib19">19. <span class="element-citation" id="sref19">Song J., Zhang X., Buscher K., et al. Endothelial basement membrane laminin 511 contributes to endothelial junctional tightness and thereby inhibits leukocyte transmigration. <span><span class="ref-journal">Cell Rep. </span>2017;<span class="ref-vol">18</span>:1256–1269.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28147279" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Rep&amp;title=Endothelial+basement+membrane+laminin+511+contributes+to+endothelial+junctional+tightness+and+thereby+inhibits+leukocyte+transmigration&amp;author=J.+Song&amp;author=X.+Zhang&amp;author=K.+Buscher&amp;volume=18&amp;publication_year=2017&amp;pages=1256-1269&amp;pmid=28147279&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib20">20. <span class="element-citation" id="sref20">Sixt M., Engelhardt B., Pausch F., et al. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. <span><span class="ref-journal">J Cell Biol. </span>2001;<span class="ref-vol">153</span>:933–946.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2174323/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11381080" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biol&amp;title=Endothelial+cell+laminin+isoforms,+laminins+8+and+10,+play+decisive+roles+in+T+cell+recruitment+across+the+blood-brain+barrier+in+experimental+autoimmune+encephalomyelitis&amp;author=M.+Sixt&amp;author=B.+Engelhardt&amp;author=F.+Pausch&amp;volume=153&amp;publication_year=2001&amp;pages=933-946&amp;pmid=11381080&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib21">21. <span class="element-citation" id="sref21">Wu C., Ivars F., Anderson P., et al. Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. <span><span class="ref-journal">Nat Med. </span>2009;<span class="ref-vol">15</span>:519–527.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19396173" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Endothelial+basement+membrane+laminin+alpha5+selectively+inhibits+T+lymphocyte+extravasation+into+the+brain&amp;author=C.+Wu&amp;author=F.+Ivars&amp;author=P.+Anderson&amp;volume=15&amp;publication_year=2009&amp;pages=519-527&amp;pmid=19396173&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib22">22. <span class="element-citation" id="sref22">Zhang X., Wang Y., Song J., et al. The endothelial basement membrane acts as a checkpoint for entry of pathogenic T cells into the brain. <span><span class="ref-journal">J&#x000a0;Exp Med. </span>2020:217.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7336306/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32379272" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J&#x000a0;Exp+Med&amp;title=The+endothelial+basement+membrane+acts+as+a+checkpoint+for+entry+of+pathogenic+T+cells+into+the+brain&amp;author=X.+Zhang&amp;author=Y.+Wang&amp;author=J.+Song&amp;publication_year=2020&amp;pages=217&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib23">23. <span class="element-citation" id="sref23">Ghazale A., Chari S.T., Zhang L., et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. <span><span class="ref-journal">Gastroenterology. </span>2008;<span class="ref-vol">134</span>:706–715.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18222442" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Immunoglobulin+G4-associated+cholangitis:+clinical+profile+and+response+to+therapy&amp;author=A.+Ghazale&amp;author=S.T.+Chari&amp;author=L.+Zhang&amp;volume=134&amp;publication_year=2008&amp;pages=706-715&amp;pmid=18222442&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib24">24. <span class="element-citation" id="sref24">European Association for the Study of the Liver  EASL clinical Practice&#x000a0;Guidelines on sclerosing cholangitis. <span><span class="ref-journal">J&#x000a0;Hepatol. </span>2022;<span class="ref-vol">77</span>:761–806.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35738507" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J&#x000a0;Hepatol&amp;title=EASL+clinical+Practice&#x000a0;Guidelines+on+sclerosing+cholangitis&amp;volume=77&amp;publication_year=2022&amp;pages=761-806&amp;pmid=35738507&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib25">25. <span class="element-citation" id="sref25">Grubman S.A., Perrone R.D., Lee D.W., et al. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. <span><span class="ref-journal">Am J Physiol. </span>1994;<span class="ref-vol">266</span>:G1060–G1070.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8023938" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol&amp;title=Regulation+of+intracellular+pH+by+immortalized+human+intrahepatic+biliary+epithelial+cell+lines&amp;author=S.A.+Grubman&amp;author=R.D.+Perrone&amp;author=D.W.+Lee&amp;volume=266&amp;publication_year=1994&amp;pages=G1060-G1070&amp;pmid=8023938&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib26">26. <span class="element-citation" id="sref26">Fuss I.J., Kanof M.E., Smith P.D., et al. Isolation of whole mononuclear cells from peripheral blood and cord blood. <span><span class="ref-journal">Curr Protoc Immunol. </span>2009</span> Chapter 7:7.1.1&#x02013;8. [<a href="https://pubmed.ncbi.nlm.nih.gov/19347849" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Protoc+Immunol&amp;title=Isolation+of+whole+mononuclear+cells+from+peripheral+blood+and+cord+blood&amp;author=I.J.+Fuss&amp;author=M.E.+Kanof&amp;author=P.D.+Smith&amp;publication_year=2009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib27">27. <span class="element-citation" id="sref27">Kizhakeyil A., Ong S.T., Fazil M.H.U.T., et al. Isolation of human peripheral blood T-lymphocytes. <span><span class="ref-journal">Methods Mol Biol. </span>2019;<span class="ref-vol">1930</span>:11–17.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30610593" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Mol+Biol&amp;title=Isolation+of+human+peripheral+blood+T-lymphocytes&amp;author=A.+Kizhakeyil&amp;author=S.T.+Ong&amp;author=M.H.U.T.+Fazil&amp;volume=1930&amp;publication_year=2019&amp;pages=11-17&amp;pmid=30610593&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib28">28. <span class="element-citation" id="sref28">Chatila T., Silverman L., Miller R., et al. Mechanisms of T cell activation&#x000a0;by&#x000a0;the calcium ionophore ionomycin. <span><span class="ref-journal">J Immunol. </span>1989;<span class="ref-vol">143</span>:1283–1289.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2545785" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Mechanisms+of+T+cell+activation&#x000a0;by&#x000a0;the+calcium+ionophore+ionomycin&amp;author=T.+Chatila&amp;author=L.+Silverman&amp;author=R.+Miller&amp;volume=143&amp;publication_year=1989&amp;pages=1283-1289&amp;pmid=2545785&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib29">29. <span class="element-citation" id="sref29">Seppen J., Rijnberg M., Cooreman M.P., et al. Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. <span><span class="ref-journal">J Hepatol. </span>2002;<span class="ref-vol">36</span>:459–465.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11943415" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hepatol&amp;title=Lentiviral+vectors+for+efficient+transduction+of+isolated+primary+quiescent+hepatocytes&amp;author=J.+Seppen&amp;author=M.+Rijnberg&amp;author=M.P.+Cooreman&amp;volume=36&amp;publication_year=2002&amp;pages=459-465&amp;pmid=11943415&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib30">30. <span class="element-citation" id="sref30">Chang J., Go S., de Waart D., et al. Soluble adenylyl cyclase regulates bile salt-induced apoptosis in human cholangiocytes. <span><span class="ref-journal">Hepatology. </span>2016;<span class="ref-vol">64</span>:522–534.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5111777/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26991014" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Soluble+adenylyl+cyclase+regulates+bile+salt-induced+apoptosis+in+human+cholangiocytes&amp;author=J.+Chang&amp;author=S.+Go&amp;author=D.+de+Waart&amp;volume=64&amp;publication_year=2016&amp;pages=522-534&amp;pmid=26991014&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib31">31. <span class="element-citation" id="sref31">Hubers L.M., Schuurman A.R., Buijs J., et al. Blue-collar work is a risk factor for developing IgG4-related disease of the biliary tract and pancreas. <span><span class="ref-journal">JHEP Rep Innov Hepatol. </span>2021;<span class="ref-vol">3</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8593662/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34816110" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JHEP+Rep+Innov+Hepatol&amp;title=Blue-collar+work+is+a+risk+factor+for+developing+IgG4-related+disease+of+the+biliary+tract+and+pancreas&amp;author=L.M.+Hubers&amp;author=A.R.+Schuurman&amp;author=J.+Buijs&amp;volume=3&amp;publication_year=2021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib32">32. <span class="element-citation" id="sref32">Maillette de Buy Wenniger L.J., Culver E.L., Beuers U. Exposure to occupational antigens might predispose to IgG4-related disease. <span><span class="ref-journal">Hepatology. </span>2014;<span class="ref-vol">60</span>:1453–1454.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4258085/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24407836" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Exposure+to+occupational+antigens+might+predispose+to+IgG4-related+disease&amp;author=L.J.+Maillette+de+Buy+Wenniger&amp;author=E.L.+Culver&amp;author=U.+Beuers&amp;volume=60&amp;publication_year=2014&amp;pages=1453-1454&amp;pmid=24407836&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib33">33. <span class="element-citation" id="sref33">L&#x000f6;hr J.-M., Beuers U., Vujasinovic M., et al. European Guideline on IgG4-related digestive disease &#x02013; UEG and SGF evidence-based recommendations. <span><span class="ref-journal">United Eur Gastroenterol J. </span>2020;<span class="ref-vol">8</span>:637–666.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8862498/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35300469" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=United+Eur+Gastroenterol+J&amp;title=European+Guideline+on+IgG4-related+digestive+disease+&#x02013;+UEG+and+SGF+evidence-based+recommendations&amp;author=J.-M.+L&#x000f6;hr&amp;author=U.+Beuers&amp;author=M.+Vujasinovic&amp;volume=8&amp;publication_year=2020&amp;pages=637-666&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib34">34. <span class="element-citation" id="sref34">Trampert D.C., van de Graaf S.F.J., Jongejan A., et al. Hepatobiliary acid-base homeostasis: insights from analogous secretory epithelia. <span><span class="ref-journal">J Hepatol. </span>2021;<span class="ref-vol">74</span>:428–441.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33342564" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hepatol&amp;title=Hepatobiliary+acid-base+homeostasis:+insights+from+analogous+secretory+epithelia&amp;author=D.C.+Trampert&amp;author=S.F.J.+van+de+Graaf&amp;author=A.+Jongejan&amp;volume=74&amp;publication_year=2021&amp;pages=428-441&amp;pmid=33342564&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib35">35. <span class="element-citation" id="sref35">Zimmer A.M., Pan Y.K., Chandrapalan T., et al. Loss-of-function approaches in comparative physiology: is there a future for knockdown&#x000a0;experiments in the era of genome editing? <span><span class="ref-journal">J Exp Biol. </span>2019;<span class="ref-vol">222</span></span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30948498" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Biol&amp;title=Loss-of-function+approaches+in+comparative+physiology:+is+there+a+future+for+knockdown&#x000a0;experiments+in+the+era+of+genome+editing?&amp;author=A.M.+Zimmer&amp;author=Y.K.+Pan&amp;author=T.+Chandrapalan&amp;volume=222&amp;publication_year=2019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib36">36. <span class="element-citation" id="sref36">El-Brolosy M.A., Stainier D.Y.R. Genetic compensation: a phenomenon in search of mechanisms. <span><span class="ref-journal">Plos Genet. </span>2017;<span class="ref-vol">13</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5509088/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28704371" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Plos+Genet&amp;title=Genetic+compensation:+a+phenomenon+in+search+of+mechanisms&amp;author=M.A.+El-Brolosy&amp;author=D.Y.R.+Stainier&amp;volume=13&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib37">37. <span class="element-citation" id="sref37">Kersten R., Trampert D.C., Herta T., et al. IgG4-related cholangitis &#x02013; a mimicker of fibrosing and malignant cholangiopathies. <span><span class="ref-journal">J Hepatol. </span>2023;<span class="ref-vol">79</span>:1502–1523.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37598939" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hepatol&amp;title=IgG4-related+cholangitis+&#x02013;+a+mimicker+of+fibrosing+and+malignant+cholangiopathies&amp;author=R.+Kersten&amp;author=D.C.+Trampert&amp;author=T.+Herta&amp;volume=79&amp;publication_year=2023&amp;pages=1502-1523&amp;pmid=37598939&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib38">38. <span class="element-citation" id="sref38">Motallebnejad P., Azarin S.M. Chemically defined human vascular laminins for biologically relevant culture of hiPSC-derived brain microvascular endothelial cells. <span><span class="ref-journal">Fluids Barriers CNS. </span>2020;<span class="ref-vol">17</span>:54.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7488267/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32912242" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Fluids+Barriers+CNS&amp;title=Chemically+defined+human+vascular+laminins+for+biologically+relevant+culture+of+hiPSC-derived+brain+microvascular+endothelial+cells&amp;author=P.+Motallebnejad&amp;author=S.M.+Azarin&amp;volume=17&amp;publication_year=2020&amp;pages=54&amp;pmid=32912242&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib39">39. <span class="element-citation" id="sref39">Kangwantas K., Pinteaux E., Penny J. The extracellular matrix protein laminin-10 promotes blood-brain barrier repair after hypoxia and inflammation in&#x000a0;vitro. <span><span class="ref-journal">J&#x000a0;Neuroinflammation. </span>2016;<span class="ref-vol">13</span>:25.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4736307/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26832174" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J&#x000a0;Neuroinflammation&amp;title=The+extracellular+matrix+protein+laminin-10+promotes+blood-brain+barrier+repair+after+hypoxia+and+inflammation+in&#x000a0;vitro&amp;author=K.+Kangwantas&amp;author=E.+Pinteaux&amp;author=J.+Penny&amp;volume=13&amp;publication_year=2016&amp;pages=25&amp;pmid=26832174&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib40">40. <span class="element-citation" id="sref40">Wu C., Ivars F., Anderson P., et al. Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. <span><span class="ref-journal">Nat Med. </span>2009;<span class="ref-vol">15</span>:519–527.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19396173" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Endothelial+basement+membrane+laminin+alpha5+selectively+inhibits+T+lymphocyte+extravasation+into+the+brain&amp;author=C.+Wu&amp;author=F.+Ivars&amp;author=P.+Anderson&amp;volume=15&amp;publication_year=2009&amp;pages=519-527&amp;pmid=19396173&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib41">41. <span class="element-citation" id="sref41">Ko S.B.H., Mizuno N., Yatabe Y., et al. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. <span><span class="ref-journal">Gastroenterology. </span>2010;<span class="ref-vol">138</span>:1988–1996.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3061436/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20080093" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Corticosteroids+correct+aberrant+CFTR+localization+in+the+duct+and+regenerate+acinar+cells+in+autoimmune+pancreatitis&amp;author=S.B.H.+Ko&amp;author=N.+Mizuno&amp;author=Y.+Yatabe&amp;volume=138&amp;publication_year=2010&amp;pages=1988-1996&amp;pmid=20080093&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib42">42. <span class="element-citation" id="sref42">Yoshikawa T., Minaga K., Hara A., et al. Disruption of the intestinal barrier exacerbates experimental autoimmune pancreatitis by promoting the translocation of <em>Staphylococcus sciuri</em> into the pancreas. <span><span class="ref-journal">Int Immunol. </span>2022;<span class="ref-vol">34</span>:621–634.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36044992" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+Immunol&amp;title=Disruption+of+the+intestinal+barrier+exacerbates+experimental+autoimmune+pancreatitis+by+promoting+the+translocation+of+Staphylococcus+sciuri+into+the+pancreas&amp;author=T.+Yoshikawa&amp;author=K.+Minaga&amp;author=A.+Hara&amp;volume=34&amp;publication_year=2022&amp;pages=621-634&amp;pmid=36044992&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib43">43. <span class="element-citation" id="sref43">Min S.-N., Wu L.-L., Zhang Y.-Y., et al. Disruption of tight junction structure contributes to secretory dysfunction in IgG4-related sialadenitis. <span><span class="ref-journal">J Mol Histol. </span>2020;<span class="ref-vol">51</span>:33–46.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31865502" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Histol&amp;title=Disruption+of+tight+junction+structure+contributes+to+secretory+dysfunction+in+IgG4-related+sialadenitis&amp;author=S.-N.+Min&amp;author=L.-L.+Wu&amp;author=Y.-Y.+Zhang&amp;volume=51&amp;publication_year=2020&amp;pages=33-46&amp;pmid=31865502&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib44">44. <span class="element-citation" id="sref44">Abe A., Takano K., Kojima T., et al. Interferon-gamma increased epithelial&#x000a0;barrier function via upregulating claudin-7 expression in&#x000a0;human submandibular gland duct epithelium. <span><span class="ref-journal">J&#x000a0;Mol Histol. </span>2016;<span class="ref-vol">47</span>:353–363.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26956365" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J&#x000a0;Mol+Histol&amp;title=Interferon-gamma+increased+epithelial&#x000a0;barrier+function+via+upregulating+claudin-7+expression+in&#x000a0;human+submandibular+gland+duct+epithelium&amp;author=A.+Abe&amp;author=K.+Takano&amp;author=T.+Kojima&amp;volume=47&amp;publication_year=2016&amp;pages=353-363&amp;pmid=26956365&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib45">45. <span class="element-citation" id="sref45">Omokawa A., Komatsuda A., Hirokawa M., et al. Membranous nephropathy with monoclonal IgG4 deposits and associated IgG4-related lung disease. <span><span class="ref-journal">Clin Kidney J. </span>2014;<span class="ref-vol">7</span>:475–478.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4379336/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25878779" ref="reftype=pubmed&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Kidney+J&amp;title=Membranous+nephropathy+with+monoclonal+IgG4+deposits+and+associated+IgG4-related+lung+disease&amp;author=A.+Omokawa&amp;author=A.+Komatsuda&amp;author=M.+Hirokawa&amp;volume=7&amp;publication_year=2014&amp;pages=475-478&amp;pmid=25878779&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10959701&amp;issue-id=456653&amp;journal-id=3793&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">JHEP Reports</span> are provided here courtesy of <strong>Elsevier</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10959701/pdf/main.pdf" class="int-view">PDF (2.8M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10959701/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10959701/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10959701" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10959701%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="TVZtzWacEqhxZYes5yqXHKYDvpWHtl45DfjDwx08MEB927q9RoRfCWYBZ2DGbB04">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10959701%2F&amp;text=Laminin%20511-E8%2C%20an%20autoantigen%20in%20IgG4-related%20cholangitis%2C%20contributes%20to%20cholangiocyte%20protection" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10959701%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10959701/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10959701/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38524667/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10959701/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38524667/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10959701/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10959701/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10959701/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
